Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40761536	u-tutkesi	— (—)	36086	137601	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other disorders of bladder

1056

3075

4.11

320.37

8.0

3.3

—

Autoimmune diseases

7408

23215

1.70

318.99

4.5

3.4

—

Other diseases of urinary system

6850

23345

1.73

318.66

5.7

3.1

—

ILD medications

7574

25865

1.67

314.72

5.3

3.2

—

Fever of other and unknown origin

3696

17970

2.03

309.10

6.0

3.3

—

Sleep apnoea, including avohilmo

6193

22560

1.88

307.65

4.4

3.8

—

Sleep apnoea

5715

22044

1.85

307.65

4.4

3.8

—

First line medication for Crohn's disease

7566

24917

1.73

307.65

5.1

3.2

—

Abnormal spermatozoa

1311

2753

6.37

307.65

4.1

4.0

—

GASTRO-related operations

5802

15944

1.91

307.65

4.3

2.9

—

Presence of other functional implants

5034

12526

3.23

307.65

4.9

3.9

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6193

24572

1.80

307.65

5.3

3.4

—

Persons encountering health services in other circumstances

4009

13609

3.43

307.65

5.1

3.3

—

Contact with and exposure to communicable diseases

3239

11098

3.37

307.65

3.7

3.3

—

ILD medications: immunosuppressive drugs

4406

21033

2.15

307.65

6.5

3.2

—

Persons with potential health hazards related to communicable diseases

3438

13388

2.86

307.65

3.9

3.4

—

Any gastric operation

5802

15944

1.91

307.65

4.3

2.9

—

Inflammatory bowel disease treatment related agents

7788

26569

1.74

307.65

5.0

3.4

—

Oral corticosteroids

7213

25410

1.80

307.65

5.0

3.4

—

Renal tubulo-interstitial diseases

5557

25253

1.77

299.55

7.2

3.2

—

Autoimmune diseases related-to ILD

5444

28616

1.75

290.35

5.0

3.6

—

Used for control exclusion in common control thyroid runs

6955

21878

1.68

285.82

4.4

3.3

—

Second line medication for Crohn's disease

3659

19745

1.97

285.03

5.3

3.7

—

Sleep disorders (combined)

6156

24683

1.71

284.48

4.4

3.7

—

ILD medications: prednisolone, methylprednisolone, prednisone

7096

25332

1.65

278.49

5.4

3.2

—

Parasetamol

5413

16155

1.78

277.61

4.2

3.0

—

Endocrine disorders, other/unspecified

372

533

12.93

274.62

4.4

3.6

—

Autoimmune diseases excluding thyroid diseases

6626

23018

1.66

268.51

5.0

3.4

—

Anaemias

1690

4385

2.77

268.45

5.5

2.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

6457

22453

1.67

264.97

5.0

3.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5958

26664

1.67

257.92

5.5

3.5

—

L04AX Other immunosuppressants

3494

19203

1.93

256.64

5.4

3.7

—

Other antidepressants

6703

22228

1.63

251.91

4.4

3.5

—

Other general symptoms and signs

561

1251

5.67

243.83

5.3

3.1

—

Cystitis

5457

20899

1.67

226.43

5.9

3.0

—

Postpartum care and examination

1339

3286

2.95

223.25

3.3

3.0

—

Any reimbursement code in KELA

3950

11242

1.84

222.87

4.0

2.5

—

General symptoms and signs

6999

23246

1.56

216.02

4.7

3.2

—

Hypothyroidism (congenital or acquired)

1972

5155

2.34

215.70

3.5

2.3

—

Other disorders of urethra and urinary system

4291

19401

1.73

214.89

6.3

3.1

—

Hypothyroidism, levothyroxine purchases

1958

5137

2.33

213.00

3.5

2.3

—

Hypothyroidism and >3 levothyroxin purchases

1958

5137

2.33

213.00

3.5

2.3

—

Polyarthropathies

4240

17072

1.73

206.28

5.3

3.5

—

Exposure to unspecified factor

5867

29951

1.58

205.01

4.8

3.6

—

Abnormalities of breathing

5753

22149

1.60

204.67

4.7

3.3

—

Spondylosis

3228

15894

1.84

199.38

4.8

3.7

—

Abdominal and pelvic pain

6267

20947

1.55

190.37

4.5

3.3

—

Hypothyroidism, strict autoimmune

4617

19270

1.65

189.41

4.1

3.4

—

Renal failure

2457

12106

1.97

189.17

9.2

3.8

—

Noninfective enteritis and colitis

2840

16157

1.85

184.87

4.8

3.8

—

Examination and observation for other reasons

1478

18770

0.46

183.80

4.9

3.3

—

Constipation

4980

23138

1.60

183.09

5.5

3.7

—

Symptoms and signs involving the digestive system and abdomen

6239

20947

1.54

182.53

4.5

3.3

—

Dental pulpitis 1, only avohilmo

6812

24353

1.51

181.64

4.0

3.7

—

Codeine

5986

21996

1.55

181.29

4.5

3.3

—

Chronic kidney disease

1715

8315

2.21

180.42

10.7

3.9

—

Genitourinary diseases

3680

10959

1.75

177.13

4.6

2.4

—

Dyspnoea

5106

25830

1.57

174.92

5.0

3.7

—

IBD patients in KELA-register

1547

7352

2.28

174.53

4.2

3.5

—

Reimbursement for rheumatic diseases

3385

20507

1.73

173.99

5.2

3.8

—

Other diseases of blood and blood-forming organs, wide

1413

6508

2.38

173.70

5.0

4.0

—

Dental pulpitis 4, only avohilmo

6754

24333

1.50

172.94

4.0

3.7

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2277

10806

1.96

172.67

4.9

4.0

—

Covid-19 confirmed case

1849

9437

2.12

172.26

5.4

3.8

—

Hypertensive diseases (excluding secondary)

3097

10385

1.81

172.16

5.1

2.9

—

Codeine or tramadol medication

6943

26854

1.48

169.20

4.5

3.6

—

Presbycusis

929

3589

2.86

167.06

5.4

4.6

—

Inflammatory bowel disease, strict (require KELA)

1547

7502

2.23

165.63

4.2

3.5

—

Endocrine, nutritional and metabolic diseases

5192

17392

1.57

165.59

4.0

3.1

—

Diseases of pulp and periapical tissues, including avohilmo

6601

23812

1.48

163.26

4.1

3.7

—

Dental pulpitis 1

6605

23843

1.48

162.88

4.1

3.7

—

Opioids

6212

22422

1.50

162.14

4.6

3.3

—

Dental pulpitis 4

6597

23841

1.48

161.53

4.1

3.7

—

Inflammatory bowel disease

1969

10505

2.00

159.50

4.5

3.6

—

Depression medications

2082

5404

2.03

158.01

3.7

2.3

—

Hypertension, essential

4268

15653

1.61

155.48

4.8

3.2

—

5-aminosalicylic acid

1367

6492

2.27

153.85

4.2

3.3

—

L04AA Selective immunosuppressants

1370

6567

2.27

151.82

9.8

3.6

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1293

6099

2.30

148.84

4.8

4.0

—

Acute tubulo-interstitial nephritis

3564

20110

1.64

148.53

7.1

3.3

—

Symptoms and signs involving the urinary system

4202

21399

1.57

146.06

6.8

3.6

—

Premature rupture of membranes

1503

5461

2.19

144.73

3.0

3.2

—

Speech therapy

139

8764

0.15

143.48

3.7

4.1

—

Hypertension

4336

16131

1.57

142.41

5.0

3.2

—

Hypertensive diseases

4337

16142

1.57

142.30

5.0

3.2

—

Other endocrine disorders

491

1418

4.02

141.95

4.4

3.5

—

Hypothyroidism, other/unspecified

5328

24344

1.49

141.33

4.1

3.7

—

Explicit Sepsis

2391

13428

1.80

140.07

7.0

3.7

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

5472

25175

1.48

139.78

4.2

3.8

—

Depression or dysthymia

4149

15188

1.58

139.41

4.4

3.5

—

Maternal care for other conditions predominantly related to pregnancy

1398

6899

2.16

137.66

3.6

3.1

—

Benzodiazepine use

5737

28877

1.46

136.51

4.7

3.7

—

Episodal and paroxysmal disorders

6688

24649

1.43

135.55

4.2

3.6

—

Other heart diseases

2706

10729

1.73

134.09

4.6

2.9

—

Disorders of other endocrine glands

2546

15123

1.74

134.08

5.5

3.8

—

Disorders of the thyroid gland

5594

25785

1.46

133.68

4.0

3.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

5003

23619

1.49

133.60

4.2

3.8

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2415

6913

1.82

133.52

3.9

2.4

—

Other bacterial diseases

5100

24540

1.48

131.84

6.0

3.5

—

Persons encountering health services in other circumstances, wide

7037

26669

1.40

130.46

5.1

3.4

—

Ulcerative colitis

1497

7831

2.04

128.95

4.4

3.6

—

Ulcerative ileocolitis

388

1073

4.43

128.43

4.3

3.6

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3443

18322

1.60

127.92

4.0

3.6

—

Fitting and adjustment of other devices

349

10745

0.29

127.81

5.7

4.1

—

Dental caries 1 and operation codes

4893

17233

1.50

127.75

4.2

3.7

—

Dental caries 3 and operation codes

5127

18257

1.48

126.56

4.2

3.7

—

Secondary hypertension

552

1882

3.26

124.70

13.8

3.0

—

Gestational diabetes (for exclusion)

2361

9961

1.77

124.44

3.1

3.2

—

Dental caries 3, only avohilmo

4735

16694

1.49

120.95

4.1

3.8

—

Special screening examination for infectious and parasitic diseases

396

8938

0.31

120.75

3.1

2.8

—

Malaise and fatigue

2698

14023

1.67

120.73

6.0

3.4

—

Disorders of gallbladder, biliary tract and pancreas

5355

24592

1.44

120.04

4.6

3.7

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

681

1890

2.89

119.69

5.1

2.9

—

Dental caries 1, only avohilmo

4444

15557

1.50

117.69

4.3

3.8

—

Pneumonia, organism unspecified

4983

25556

1.45

117.29

5.4

3.5

—

Tramadol

4264

18821

1.50

116.57

5.2

3.4

—

Other obstetric conditions, not elsewhere classified

2212

8542

1.78

116.41

3.7

2.9

—

Dental pulpitis 2, only avohilmo

4027

13860

1.53

116.39

4.2

3.7

—

Drug-induced neutropenia

527

1864

3.29

115.97

5.1

4.0

—

Sulfasalazine

1655

9237

1.89

115.60

4.8

3.4

—

Concussion

2884

15998

1.62

115.24

4.7

3.3

—

Dental caries 3

4641

16468

1.48

114.36

4.1

3.7

—

Ulcerative colitis (strict definition, require KELA)

1068

5193

2.23

113.93

4.2

3.5

—

Septicaemia

2172

12606

1.74

113.79

7.2

3.8

—

Dental caries 1

4358

15306

1.50

113.19

4.2

3.7

—

Hyperlipidaemia, other/unspecified

2095

11889

1.75

112.84

5.2

3.9

—

Atrial fibrillation and flutter

1701

6134

1.89

112.46

4.6

3.0

—

Dental caries, including avohilmo

4351

15301

1.50

112.38

4.2

3.7

—

Symptoms and signs involving the circulatory and respiratory systems

6074

22223

1.40

112.16

4.3

3.3

—

Retention of urine

1776

8562

1.85

112.15

7.2

3.5

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2163

8387

1.77

111.88

3.7

2.9

—

Other disorders of fluid, electrolyte and acid-base balance

1651

8964

1.88

111.82

7.0

4.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1035

5016

2.24

111.48

4.2

3.5

—

Selective serotonin reuptake inhibitors

5824

22284

1.41

111.39

4.2

3.6

—

Intracranial trauma

3333

16512

1.56

111.39

4.7

3.2

—

Dental pulpitis 2

3934

13614

1.52

111.00

4.2

3.7

—

ILD medications: azathioprine

924

4288

2.33

110.79

6.9

3.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1122

5610

2.15

110.70

4.2

3.6

—

Spondylopathies

4404

18650

1.48

110.32

4.7

3.6

—

Cardiovascular diseases (excluding rheumatic etc)

3823

14944

1.52

110.17

4.5

2.8

—

6578

25802

1.38

110.11

4.8

3.5

—

COPD/asthma related infections

6146

22581

1.40

110.03

4.7

3.4

—

COPD/asthma/ILD related infections

6146

22581

1.40

110.03

4.7

3.4

—

Bronchitis

6037

29209

1.39

110.00

4.9

3.6

—

Heart failure and antihypertensive medication

1282

4300

2.08

109.63

6.4

3.3

—

Azathioprine

924

4309

2.32

109.46

6.9

3.3

—

Diabetes mellitus in pregnancy

2071

7960

1.78

109.44

3.2

3.1

—

Finngen Rheumatological endpoints

5613

23261

1.41

109.22

4.5

3.4

—

Other septicaemia

1948

11351

1.77

109.04

7.5

3.8

—

False labour

1867

6766

1.83

107.79

3.6

3.2

—

Non-rheumatic valve diseases

2445

11142

1.67

106.75

4.9

3.8

—

Other arthritis (FG)

1726

9984

1.82

106.72

5.0

3.5

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5003

22520

1.43

106.49

5.3

3.4

—

5003

22520

1.43

106.49

5.3

3.4

—

877

4072

2.35

105.89

5.7

3.3

—

Invasive ventilation

512

1868

3.13

105.71

6.5

3.9

—

Valvular heart disease excluding rheumatic fever

2450

11213

1.66

105.53

4.9

3.8

—

Asthma, unspecified (mode), excluding more controls

2875

14734

1.59

104.48

4.6

3.2

—

Other soft tissue disorders, not elsewhere classified

5352

24120

1.41

103.84

4.9

3.5

—

Complications of surgical and medical care, not elsewhere classified

5293

27771

1.40

103.40

5.3

3.6

—

Disorders of lens

3383

14346

1.54

102.85

5.2

3.8

—

Neurological diseases, wide definition

2036

5999

1.77

102.79

4.0

2.5

—

Medical observation and evaluation for suspected diseases and conditions

2363

18935

0.62

101.56

4.5

3.3

—

Acute bronchitis

2225

13641

1.67

101.10

5.6

3.9

—

Any event in cancer register

4994

21429

1.42

100.88

4.2

3.6

—

Other heart diseases, wide

5020

22610

1.41

99.96

4.6

3.4

—

Extreme obesity with alveolar hypoventilation

333

985

4.09

99.68

5.6

3.7

—

Meniscus derangement

3021

13712

1.56

99.56

4.4

3.6

—

Hernia of abdominal wall, postoperative

919

4418

2.21

99.53

5.9

3.1

—

Asthma, unspecified (mode)

2932

15410

1.56

99.23

4.6

3.2

—

Unspecified haematuria

2113

11185

1.69

99.07

6.9

3.5

—

Type 2 diabetes, wide definition

4009

18349

1.47

97.82

5.6

3.8

—

Cardiac arrhythmias

3379

15185

1.52

97.81

4.3

3.2

—

Other maternal disorders predominantly related to pregnancy

3296

14034

1.53

97.78

3.8

3.6

—

Crohn disease

830

3905

2.31

96.84

4.7

3.5

—

Mucosal proctocolitis

809

3774

2.33

96.37

4.2

3.5

—

Heart failure, not strict

3718

17855

1.48

96.05

6.6

3.6

—

Malignant neoplasm

4595

19607

1.43

95.90

4.3

3.7

—

Acute upper respiratory infections of multiple and unspecified sites

4141

22101

1.44

95.58

4.9

3.5

—

Diabetes, varying definitions

5576

24749

1.38

95.58

4.7

3.6

—

Neurological diseases

5286

19503

1.40

95.40

4.1

3.3

—

Other diseases of pleura

2213

12384

1.65

95.38

5.5

4.1

—

Senile cataract

3081

12799

1.54

95.15

5.0

3.9

—

Other specified/unspecified arthritis

1506

8666

1.83

95.05

5.1

3.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2445

9882

1.62

94.65

4.6

2.9

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

921

4539

2.18

94.49

5.6

4.0

—

Diabetes mellitus

5600

24885

1.38

94.44

4.7

3.6

—

L04AD Calcineurin inhibitors

644

2774

2.56

93.22

14.1

3.5

—

Pain in throat and chest

4620

20462

1.41

92.71

4.7

3.4

—

Hyperplasia of prostate

1766

5916

1.77

92.36

4.7

3.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

3853

24921

1.45

91.99

5.4

3.6

—

Atrial fibrillation and flutter with reimbursement

1365

4809

1.91

91.76

4.7

3.1

—

Any operation in hilmo

262

276

5.09

91.67

3.4

1.5

—

Type 2 diabetes

5260

23153

1.38

91.30

4.7

3.6

—

Headache

3573

20954

1.47

91.22

5.0

3.2

—

Maternal care for other known or suspected fetal problems

1501

5501

1.85

90.30

3.4

3.0

—

Implicit Sepsis

3722

20509

1.45

89.02

6.2

3.6

—

Cholelithiasis

4394

22408

1.41

88.90

4.5

3.8

—

Gastrointestinal diseases

3798

13332

1.47

88.87

4.0

3.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5012

22630

1.38

88.86

4.9

3.6

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2241

14500

1.61

88.75

5.1

3.7

—

Pain (limb, back, neck, head abdominally)

4301

15442

1.43

88.40

4.3

3.2

—

Ulcerative rectosigmoiditis

552

2279

2.69

88.09

4.5

3.5

—

Agranulocytosis

676

3051

2.44

88.02

5.1

3.9

—

Pneumonias (Asthma/COPD co-morbidities)

5364

27931

1.36

87.30

5.3

3.5

—

Cholelithiasis, broad definition with cholecystitis

4534

22765

1.40

87.23

4.5

3.8

—

Malignant neoplasm, wide definition for exclusion

4552

19633

1.40

87.15

4.3

3.7

—

Glaucoma

2721

16093

1.54

87.09

4.6

4.3

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

4551

19630

1.40

87.08

4.3

3.7

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

4550

19627

1.40

87.06

4.3

3.7

—

All pneumoniae

5400

28058

1.36

86.85

5.3

3.5

—

Acute upper respiratory infections

5769

27439

1.35

86.08

4.6

3.6

—

Pain in limb

4341

22952

1.41

85.56

5.1

3.5

—

Other and unspecified anaemias

2045

12624

1.63

85.54

6.1

4.1

—

Nausea and vomiting

1422

8143

1.80

85.48

6.4

3.5

—

Other Crohn's disease

483

1904

2.84

85.23

4.5

3.4

—

Sequelae with surgical and medical care as external cause

1087

5895

1.97

84.58

5.6

4.1

—

Cardiovascular diseases

3695

14214

1.46

84.50

4.3

2.8

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

867

4364

2.14

84.18

4.0

3.5

—

Antihypertensive medication - note that there are other indications

3677

14205

1.45

84.14

4.2

2.9

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5209

27562

1.36

83.92

5.3

3.5

—

Cardiodefibrillation

1768

10960

1.69

83.85

4.8

4.3

—

Biological medication for rheuma

924

4767

2.08

83.66

4.7

3.5

—

Other anaemias

2055

12742

1.62

83.31

6.1

4.1

—

Aplastic and other anaemias

2201

13613

1.59

83.19

6.2

4.1

—

Hypertrophy of (infrapatellar) fat pad

139

242

8.40

83.09

3.6

2.9

—

Other hearing loss

1407

8102

1.79

83.00

5.3

4.3

—

Intracranial injury

3025

20334

1.48

82.95

4.9

3.7

—

Hydronephrosis

657

2995

2.39

82.93

7.8

3.4

—

Ulcerative colitis, NAS

830

4141

2.16

82.59

4.6

3.6

—

Diabetes, insulin treatment (Kela reimbursement)

5206

23991

1.36

81.52

4.9

3.7

—

General examination and investigation of persons without complaint and reported diagnosis

2383

18897

0.65

81.26

4.7

3.3

—

Type 2 diabetes, definitions combined

4918

21926

1.37

81.23

4.5

3.6

—

Type 2 diabetes, strict (exclude DM1)

4940

22063

1.37

80.89

4.5

3.7

—

Diabetes medication

5486

25340

1.35

80.82

4.7

3.6

—

Insulin medication

3035

18092

1.48

80.80

5.6

3.8

—

Type 2 diabetes, definitions combined, including avohilmo

4963

21994

1.37

80.74

4.5

3.6

—

Internal derangement of knee

2021

13002

1.61

80.71

4.2

3.5

—

Other retinal disorders

3089

17378

1.47

79.73

5.0

4.1

—

Other medical care

2146

13752

1.59

79.64

5.1

3.8

—

Glomerular diseases

965

5131

2.01

79.56

12.2

3.7

—

Primary open-angle glaucoma, strict

1303

7567

1.81

79.36

4.5

4.6

—

Recurrent or chronic depression

2184

10267

1.59

79.26

4.0

3.3

—

Lyme disease

281

8083

0.33

78.83

4.1

4.0

—

Adjustment and management of implanted device

1001

5414

1.97

78.39

4.9

4.1

—

Other acute lower respiratory infections

2765

18246

1.49

78.21

5.4

3.8

—

Intestinal infectious diseases

5039

29794

1.35

77.58

5.3

3.6

—

Other spirochaetal diseases

293

8187

0.34

77.29

4.2

4.0

—

Oxycodone

1731

10541

1.65

76.51

6.1

3.7

—

malignant neoplasm of male genital organs

1876

7548

1.64

75.19

4.0

—

Other diseases of intestines

5884

26482

1.32

75.03

4.7

3.4

—

Adrenocortical insufficiency

280

890

3.73

74.68

6.8

3.7

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1451

5255

1.76

74.62

3.9

3.7

—

Acute renal failure

1010

5566

1.92

74.11

7.8

3.8

—

Dental operations

3447

12596

1.44

74.04

4.2

3.6

—

Presence of other devices

180

6336

0.27

73.94

4.7

4.0

—

Metabolic disorders

4832

22710

1.35

73.78

5.3

3.6

—

Diseases of male genital organs

2382

7980

1.55

73.64

4.5

3.2

—

Methotrexate

827

4289

2.06

73.42

5.6

3.6

—

Supervision of high-risk pregnancy

1261

4385

1.84

73.24

3.6

3.1

—

Malignant neoplasm of prostate

1831

7331

1.64

73.11

4.0

—

Influenza and pneumonia

5626

28659

1.32

73.01

5.3

3.5

—

Disorders of choroid and retina

3916

21039

1.39

72.88

4.8

4.0

—

Insulin, fast-acting

1849

11994

1.60

72.21

6.0

3.7

—

Transplanted organ and tissue status

524

2303

2.48

72.04

16.5

3.5

—

Other pulmonary diagnosis

4657

17522

1.36

71.66

4.4

3.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

4273

23278

1.37

71.32

5.7

3.5

—

Hypo-osmolality and hyponatraemia

911

4921

1.97

70.90

7.1

4.0

—

Continuous positive airway pressure

129

4655

0.23

70.78

4.6

3.2

—

Tumor necrosis factor alpha inhibitors

819

4300

2.04

70.51

4.8

3.5

—

COPD differential diagnosis

4630

17449

1.36

70.44

4.4

3.2

—

Insulin, combination of fast acting with intermediate-acting or long-acting

3040

20070

1.44

70.41

5.6

3.8

—

Cholecystectomy

3507

22717

1.40

70.38

4.6

3.9

—

Excluding asthma or asthma-COPD overlap

4645

17522

1.36

70.24

4.4

3.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

2886

20549

1.45

69.99

5.2

3.9

—

ILD differential diagnosis

4625

17445

1.36

69.94

4.4

3.2

—

Sequelae of external causes of morbidity and mortality

1284

7722

1.75

69.43

5.5

4.0

—

Other disorders of adrenal gland

327

1182

3.19

69.27

6.9

3.6

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1394

5005

1.74

69.12

4.0

3.7

—

Primary open-angle glaucoma

1504

9168

1.67

68.87

4.6

—

Exclusions for E4_PCOS_BROAD

933

5140

1.93

68.78

5.5

3.7

—

Other arrhythmias

3233

17913

1.42

68.41

4.5

3.5

—

Venous thromboembolism

2583

17575

1.47

68.26

5.4

4.1

—

Insulin, intermediate and long-acting

2670

18485

1.46

67.92

5.5

3.8

—

1000

5328

1.88

67.71

5.3

4.7

—

Other cataract

1989

10209

1.56

67.36

5.5

3.9

—

Hypothyroidism, drug reimbursement

768

2782

2.07

67.12

4.2

2.3

—

FESS (DNB20)

709

3607

2.12

67.10

3.8

3.7

—

Coxibs

1667

5569

1.65

66.67

3.9

—

Certain infectious and parasitic diseases

5730

22421

1.30

66.21

4.7

3.2

—

Asthma, excluding more controls

4156

16598

1.36

65.93

4.3

3.1

—

Insulin, fast-acting or short human

1856

12314

1.56

65.29

6.0

3.8

—

Injuries to the head

5840

30044

1.29

64.93

4.6

3.7

—

Dental operations, only avohilmo

3629

13663

1.39

64.65

4.2

3.8

—

Outcome of delivery

181

3672

0.29

64.22

2.6

3.0

—

Adalimumab

536

2505

2.33

63.96

5.1

3.5

—

Other (not insulin) diabetes medications

4889

22775

1.32

63.82

4.5

3.7

—

Glomerular disorders in diseases classified elsewhere

624

3102

2.17

63.03

12.6

3.7

—

Asthma

4272

17369

1.35

62.69

4.3

3.2

—

Ischaemic heart disease, wide definition

3648

16998

1.38

62.57

5.2

3.9

—

Iron deficiency anaemia

2016

13598

1.52

62.46

5.8

4.0

—

Dermatographic urticaria

447

1967

2.52

62.38

4.7

3.6

—

212

640

4.09

62.36

5.0

2.9

—

Depression

5089

27401

1.30

62.03

4.5

3.6

—

Mood disorders, excluding more controls

5075

24080

1.31

61.95

4.6

3.6

—

Other disorders of amniotic fluid and membranes

794

4263

1.97

61.86

3.1

3.2

—

Arthropathies

5238

20782

1.31

61.83

4.1

3.4

—

Diseases of the skin and subcutaneous tissue

5801

22965

1.29

61.72

4.5

3.4

—

Complications of procedures, not elsewhere classified

4031

26575

1.34

61.32

5.2

3.7

—

Glaucoma suspect

1671

11010

1.58

61.18

4.5

4.3

—

Diseases of the musculoskeletal system and connective tissue

3370

12385

1.40

61.11

4.0

3.0

—

Ethmoidectomy

713

3757

2.03

60.83

3.8

3.7

—

In situ neoplasms

1690

10639

1.57

60.82

4.9

3.8

—

Psoriatic and enteropathic arthropathies

645

3290

2.10

60.29

4.6

3.4

—

Heart failure,strict

2410

12240

1.46

59.71

6.1

3.8

—

Dermatitis

3031

22347

1.39

59.61

5.1

3.7

—

Obesity due to excess calories

2356

16689

1.46

59.38

5.0

3.6

—

Nutritional anaemias

2321

15945

1.46

59.01

5.7

4.0

—

Mood [affective] disorders

5455

28449

1.29

58.97

4.5

3.7

—

Mood disorders

5466

28474

1.28

58.93

4.5

3.7

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2376

9793

1.47

58.68

3.5

3.4

—

Other functional intestinal disorders

2236

14954

1.47

58.39

6.1

3.7

—

Bleeding

3943

21904

1.34

58.08

5.4

3.9

—

Pulmonary heart disease, diseases of pulmonary circulation

1481

9615

1.60

57.88

5.8

4.2

—

Biguanides

4752

22854

1.31

57.76

4.4

3.8

—

ILD, hospital admissions

733

3970

1.97

57.39

5.3

4.2

—

Crohn's disease of large intestine

341

1378

2.76

57.32

4.8

3.5

—

1293

7202

1.66

57.10

5.2

4.6

—

Pacemaker

1496

9490

1.59

56.98

5.0

4.4

—

Paracetamol of NSAID medication

1054

3056

1.79

56.92

3.6

3.0

—

Pregnancy examination and test

995

3601

1.82

56.88

3.6

3.0

—

Other joint disorders

4972

20755

1.30

56.85

4.0

3.4

—

Disorders of thyroid, IBD co-morbidities

987

4179

1.79

56.71

3.9

2.5

—

Psychiatric diseases

6011

24109

1.27

56.65

4.5

3.5

—

Non-invasive ventilation

262

6320

0.37

56.57

6.1

3.1

—

Thrombocytopenia, unspecified

415

1847

2.48

56.21

5.6

3.9

—

Other diseases of hard tissues of teeth

3330

18616

1.37

56.14

4.5

3.5

—

Other noninfective gastroenteritis and colitis

1223

7653

1.67

56.05

5.4

3.9

—

Obesity related asthma

1615

10764

1.56

56.04

5.1

3.8

—

Other interstitial pulmonary diseases

738

4042

1.94

55.74

5.3

4.3

—

Rheumatoid arthritis

1606

9693

1.56

55.68

5.4

3.7

—

Interstitial lung disease

738

4044

1.94

55.66

5.3

4.2

—

Interstitial lung disease endpoints

738

4044

1.94

55.66

5.3

4.2

—

Other external causes of accidental injury

4825

18904

1.30

55.38

4.1

3.4

—

Delivery

2085

7596

1.50

55.14

3.9

4.2

—

Haemorrhage in early pregnancy

1457

9307

1.59

54.97

3.8

3.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1517

10019

1.57

54.88

4.4

3.2

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1143

7085

1.69

54.73

4.7

3.7

—

Nephropathy related operations

618

3218

2.05

54.61

15.5

3.7

—

Pleural effusion

735

4045

1.92

54.40

5.3

4.1

—

Acetic acid derivatives and related substances

1617

5499

1.58

54.38

3.9

—

Ischemic heart diseases

3647

17382

1.34

53.88

5.2

3.9

—

Heart failure, strict

2605

13617

1.42

53.85

6.1

4.1

—

Artificial joint operation, meniscal resection

4316

22379

1.31

53.81

4.4

4.0

—

Personal history of other diseases and conditions

642

3387

2.02

53.79

4.1

3.1

—

Crohn's disease NAS

397

1766

2.46

53.64

5.2

3.6

—

Asthma (mode)

4118

17445

1.32

53.57

4.3

3.2

—

Abnormalities of heart beat

1752

11857

1.51

53.50

5.2

3.5

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

1118

4761

1.70

53.35

5.9

3.1

—

Kidney transplant status

315

1272

2.76

53.14

23.4

3.4

—

Neoplasms

4335

18054

1.31

53.09

3.9

3.3

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

424

1950

2.38

52.98

4.4

3.5

—

Haemorrhage from respiratory passages

1609

10023

1.54

52.92

5.0

3.7

—

Paroxysmal tachycardia

1116

5814

1.69

52.88

4.8

3.0

—

Delivery, wide proxy

1823

6568

1.53

52.72

4.0

4.2

—

Syncope and collapse

2155

13540

1.45

52.68

5.2

3.5

—

Gout

1220

7036

1.64

52.57

6.4

3.8

—

All-cause Heart Failure

2561

13422

1.41

52.50

6.1

4.1

—

Drug-induced adrenocortical insufficiency

154

422

4.57

52.41

8.2

3.7

—

Diseases of the ear and mastoid process

6420

26448

1.25

52.29

4.2

3.6

—

Oedema, not elsewhere classified

1456

9573

1.57

52.26

5.9

3.6

—

Fall on same level

6214

28226

1.25

52.17

4.5

3.6

—

Crohn disease (strict definition, require KELA)

403

1828

2.42

52.17

4.4

3.5

—

DVT of lower extremities and pulmonary embolism

1902

13219

1.48

52.15

5.6

4.1

—

Schizophrenia or delusion, excluding more controls

1502

9927

1.55

51.83

4.3

3.4

—

Diseases of the digestive system

2151

15315

1.44

51.72

5.3

4.0

—

Crohn disease (strict definition, require KELA, min 2 HDR)

396

1790

2.43

51.71

4.3

3.5

—

Endometriosis of pelvic peritoneum

885

5155

1.78

51.32

4.3

3.3

—

Polyarthrosis

953

5489

1.74

51.30

5.8

4.0

—

Pulmonary embolism

1344

8780

1.59

51.17

5.8

4.2

—

Accidents

4782

18904

1.29

51.11

4.1

3.4

—

ILD, hospital admission 2, with pulmonary infections

480

2340

2.21

51.07

6.0

3.8

—

Acute sinusitis

2624

18044

1.39

50.94

4.8

3.4

—

Anxiety disorders, excluding more controls

4311

22430

1.30

50.89

4.7

3.5

—

Coagulation defects, purpura and other haemorrhagic conditions

962

5828

1.74

50.78

5.6

3.8

—

Pulmonary heart disease

1344

8799

1.59

50.68

5.8

4.2

—

Any mental disorder

6065

24661

1.25

50.52

4.5

3.6

—

Collagenous colitis

482

2377

2.19

50.07

5.7

4.1

—

Diseases of the eye and adnexa

4656

18395

1.29

49.92

4.1

3.2

—

Use of hypnotics and sedatives

5432

25318

1.26

49.78

4.6

3.7

—

Degeneration of macula and posterior pole

2062

12084

1.45

49.60

4.8

4.4

—

Other nutritional deficiencies

3214

24021

1.34

49.19

4.8

3.6

—

Coronary atherosclerosis

3109

15128

1.36

49.18

5.3

4.0

—

Dialysis, with operation codes

610

3276

1.98

48.95

15.0

3.5

—

Other respiratory diseases principally affecting the interstitium

826

4855

1.79

48.82

5.3

4.3

—

Anxiety disorders

4652

26280

1.28

48.80

4.6

3.6

—

Normotensive glaucoma

448

2177

2.24

48.67

4.7

4.5

—

Other and unspecified iron deficiency

1539

10452

1.53

48.64

5.9

4.0

—

Single spontaneous delivery

2027

7573

1.47

48.63

3.9

4.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4692

24344

1.28

48.56

4.8

3.7

—

Asthma (only as main-diagnosis), excluding more controls

3619

16598

1.32

48.52

4.3

3.1

—

Other diseases of liver

860

5122

1.77

48.44

4.7

3.9

—

Vocal cord dysfunction

643

3247

1.92

48.21

4.7

2.8

—

194

643

3.51

48.12

4.2

3.2

—

Cerebrovascular diseases (FINNGEN)

1425

6747

1.56

47.95

5.2

3.0

—

Temporomandibular joint disorders

839

4969

1.77

47.87

4.4

3.0

—

Morphin

138

370

4.49

47.80

4.4

3.7

—

Falls/tendency to fall

6131

25121

1.24

47.52

4.3

3.5

—

Diseases of liver

1545

10552

1.52

47.48

4.8

3.9

—

Other systemic involvement of connective tissue (FG)

1261

8206

1.59

47.45

5.7

3.7

—

Other diseases of blood and blood-forming organs

383

1771

2.36

47.26

4.5

3.9

—

Gout, unspecified

896

5436

1.73

46.98

6.5

4.0

—

Neuromuscular dysfunction of bladder

465

2315

2.15

46.78

9.2

3.1

—

Dorsalgia

5476

24063

1.25

46.75

4.6

3.5

—

Mental and behavioural disorders due to psychoactive substance use

2848

20342

1.35

46.52

4.2

3.7

—

Other/unspecified dorsalgia

1890

13383

1.45

46.29

5.1

3.6

—

Kela-code for severe mental illness

1808

12777

1.46

46.13

4.4

3.7

—

Other and unspecified dermatitis

2455

18252

1.38

45.98

5.1

3.8

—

Asthma (only as main-diagnosis)

3698

17369

1.31

45.69

4.4

3.2

—

Systemic connective tissue disorders

1684

11785

1.48

45.64

6.3

4.0

—

Budesonide

678

3843

1.86

45.52

4.8

3.3

—

Neurotic, stress-related and somatoform disorders

4571

26076

1.27

45.27

4.6

3.6

—

External causes of morbidity and mortality

3900

15270

1.30

45.20

4.1

3.3

—

Endometriosis

1965

8318

1.45

44.77

4.3

3.5

—

Gastro-oesophageal reflux disease

3292

22614

1.32

44.71

4.8

3.8

—

Complications of medical and surgical care

3480

25847

1.31

44.54

5.4

3.8

—

Pregnancy, childbirth and the puerperium

1585

5653

1.52

44.29

4.2

4.3

—

Persons encountering health services for examination and investigation

2884

18938

0.75

44.20

4.4

3.3

—

Low back pain

3802

23104

1.29

44.09

5.0

3.5

—

Other disorders of kidney and ureter

621

3471

1.90

44.07

9.9

4.0

—

Maternal care for known or suspected abnormality of pelvic organs

1283

5857

1.57

43.70

3.5

3.2

—

Bacterial infection, other or unspecified

2366

15868

1.38

43.58

6.5

3.7

—

Other disorders of white blood cells

326

1464

2.46

43.46

4.9

3.8

—

Sensorineural hearing loss

3473

18968

1.31

43.42

4.8

4.0

—

Purpura and other haemorrhagic conditions

663

3793

1.85

43.40

5.7

3.9

—

Dermatitis and eczema

5594

30162

1.24

43.33

4.7

3.7

—

Bacterial Sepsis

1986

12789

1.42

43.29

7.1

3.7

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

878

5415

1.70

43.29

4.5

3.4

—

Pre-eclampsia or poor fetal growth

1611

11281

1.48

43.16

4.0

3.3

—

Care involving dialysis

413

2033

2.19

43.11

17.8

3.6

—

Open wound of head

2365

17376

1.37

42.97

4.8

3.8

—

Single delivery by caesarean section

941

3334

1.70

42.97

3.4

—

Psoriasis

1329

8995

1.53

42.90

4.4

3.8

—

Spondylopathies (FG)

717

4200

1.79

42.90

4.5

3.3

—

Other or unspecified ileus, impaction or obstruction

867

5333

1.70

42.86

5.9

3.8

—

Gout, idiopatic and unspecified

1042

6704

1.62

42.75

6.5

4.1

—

6-mercaptopurine

209

770

3.06

42.55

4.2

3.1

—

Obesity

3007

23033

1.32

42.49

4.8

3.6

—

Gout, strict definition

779

4682

1.75

42.47

6.5

4.1

—

Other CVD (FINNGEN)

544

2291

1.97

42.19

6.5

3.2

—

2709

18951

1.34

42.17

4.3

3.7

—

ILD, hospital admissions 3, with pneumonia sepsis

406

2001

2.18

42.13

6.0

3.9

—

Soft tissue disorders

5719

24456

1.23

42.11

4.4

3.5

—

Psoriatic arthropathies

516

2762

1.98

41.89

4.4

3.5

—

Inflammatory diseases of prostate (prostatitis)

553

3019

1.93

41.83

5.2

3.3

—

Obesity and other hyperalimentation

3014

23126

1.32

41.81

4.8

3.6

—

Paralytic ileus and intestinal obstruction

1180

7829

1.56

41.80

5.7

3.8

—

Spondyloarthritis

868

5371

1.68

41.80

5.0

3.6

—

Intestinal malabsorption

278

1186

2.60

41.78

5.4

3.7

—

2850

19607

1.33

41.65

4.3

3.7

—

Other disorders of ear

4399

23624

1.26

41.41

4.6

3.8

—

Non-selective monoamine reuptake inhibitors

1746

12114

1.44

41.26

5.3

3.8

—

Viral hepatitis, IBD co-morbidity

271

1135

2.54

41.19

4.1

2.6

—

Glucagon-like peptide-1 (GLP-1) analogues

2416

14932

1.36

41.09

5.5

4.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1706

15538

0.70

41.00

4.0

3.4

—

Substance abuse, excluding more controls

2646

17644

1.34

40.83

4.3

3.5

—

Other reaction to severe stress, and adjustment disorders

1889

13743

1.41

40.81

5.0

3.3

—

Mouth breathing

1800

12978

1.42

40.72

4.5

3.8

—

Mental and behavioural disorders due to alcohol

2372

17368

1.36

40.71

4.2

3.7

—

ILD, hospital admissions 1, main diag only

615

3515

1.85

40.47

5.4

4.2

—

Symptoms and signs involving appearance and behaviour

218

5.70

40.45

4.7

3.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1517

10670

1.47

40.12

4.4

3.4

—

Infective dermatitis

586

3314

1.87

39.99

4.9

3.8

—

Persons encountering health services for specific procedures, not carried out

438

2265

2.08

39.97

5.6

3.4

—

Infections, IBD-co-morbidities

724

3099

1.76

39.89

7.2

2.7

—

Intestinal stricture

1343

9242

1.50

39.80

5.6

4.1

—

Single delivery by forceps and vacuum extractor

780

2838

1.75

39.74

3.1

3.3

—

Eosinophilic disease (BM)

127

367

4.17

39.67

4.9

2.9

—

Exclusions for E4_PCOS_CONSORTIUM

3753

18716

1.28

39.55

4.4

3.7

—

Other symptoms and signs involving the digestive system and abdomen

782

4788

1.71

39.46

6.0

3.5

—

Gout, FINNGEN

1220

8253

1.53

39.42

6.4

4.0

—

Personality disorders, excluding more controls

1312

9007

1.51

39.36

4.5

3.1

—

In situ neoplasms

1690

12170

1.43

39.07

4.9

4.0

—

Crohn's disease of small intestine

386

1924

2.16

39.05

4.6

3.5

—

Schizophrenia, schizotypal and delusional disorders

1511

10669

1.46

38.86

4.3

3.7

—

Rheumatoid arthritis, including avohilmo

1775

12896

1.42

38.75

5.3

4.1

—

Provisional assignment of new diseases of uncertain etiology

2191

16442

1.37

38.71

5.3

3.6

—

Diagnoses used for exclusion with ILD

1140

7637

1.55

38.68

4.9

4.0

—

Codes for special purposes

2194

16470

1.37

38.67

5.3

3.6

—

Rheumatism, unspecified

709

4266

1.75

38.62

5.6

3.7

—

Other specified/unspecified inflammatory spondylopathies

293

1321

2.42

38.48

4.7

3.2

—

Schizophrenia or delusion

1502

10619

1.46

38.36

4.3

3.7

—

Other and unspecified tonsillitis

1733

10619

1.42

38.12

3.9

3.0

—

Heart failure and bmi 25plus

1658

8174

1.44

37.94

6.0

4.2

—

Covid-19 suspected case

375

7187

0.50

37.51

5.1

3.4

—

2123

15795

1.37

37.51

5.1

3.7

—

Eosinophilia

127

382

3.99

37.38

4.9

3.7

—

Disorders of mineral metabolism

422

2205

2.05

37.28

5.6

3.7

—

Chronic nephritic syndrome

240

1010

2.64

37.25

15.0

3.6

—

Arthropathic psoriasis

552

3137

1.86

37.07

4.4

3.7

—

Other diseases of biliary tract

415

2157

2.06

37.06

5.4

4.1

—

Respiratory conditions due to other external agents

143

465

3.61

36.93

4.5

4.1

—

Dialysis

229

946

2.68

36.89

20.9

3.2

—

Other ulcerative colitis

321

1529

2.27

36.71

4.4

3.5

—

Chronic pancreatitis

551

3140

1.85

36.49

5.5

3.8

—

Gonarthrosis [arthrosis of knee](FG)

3455

16149

1.28

36.28

4.4

3.6

—

Volume depletion

450

2417

1.98

36.26

7.3

3.9

—

Poisoning by drugs, medicaments and biological substances

1190

8155

1.51

36.23

4.5

3.5

—

Anxiety (asthma-related co-morbidities)

2971

18394

1.30

36.07

4.3

3.4

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

498

2750

1.89

36.04

6.7

4.0

—

Chronic lower respiratory diseases

6309

28798

1.20

35.95

4.3

3.7

—

Glomerulonephritis

489

2708

1.92

35.86

12.7

3.8

—

Primary_lymphoid and hematopoietic malignant neoplasms

976

6436

1.57

35.62

4.6

4.0

—

Respiratory insufficiency

384

1968

2.07

35.31

6.4

3.6

—

Conductive and sensorineural hearing loss

3606

20068

1.27

35.25

4.7

4.0

—

Poisoning by medicine

1088

7374

1.53

35.12

4.6

3.5

—

Certain disorders involving the immune mechanism

872

5642

1.61

35.08

6.9

3.8

—

Varicose veins

2859

16934

1.30

35.04

4.6

4.0

—

Carrier of infectious disease

165

599

3.16

34.93

6.0

3.5

—

Sicca syndrome [Sjögren]

443

2404

1.97

34.91

6.1

4.0

—

Other diseases of the respiratory system

877

5693

1.60

34.63

5.9

4.3

—

Other respiratory disorders and diseases

877

5693

1.60

34.63

5.9

4.3

—

Implicit viral Sepsis

861

5573

1.61

34.50

7.9

3.7

—

Supervision of normal pregnancy

1179

4575

1.52

34.38

3.2

3.1

—

Pleural plaque

448

2450

1.94

34.22

4.4

4.0

—

Viral Sepsis

861

5586

1.60

34.15

7.9

3.7

—

Excessive vomiting in pregnancy

455

2507

1.94

34.13

4.4

3.2

—

Extracorporeal dialysis

310

1501

2.24

34.11

16.4

3.7

—

Gingivitis and periodontal diseases

4710

20058

1.23

34.11

4.2

3.6

—

Tracheo-bronchomalasia

8.12

34.06

4.0

3.1

—

Dorsopathies

5657

24229

1.21

34.03

4.3

3.5

—

Pain in joint

2821

14627

1.30

33.93

4.4

3.2

—

Asthma, hospital admission 2, infections

2753

21319

1.30

33.80

5.0

3.8

—

Asthma-related infections

2753

21319

1.30

33.80

5.0

3.8

—

Diseases of oral cavity, salivary glands and jaws

4762

20190

1.23

33.72

4.3

3.6

—

Urolithiasis

1409

10094

1.44

33.50

5.2

3.9

—

Other systemic involvement of connective tissue

1278

9011

1.47

33.47

5.7

4.0

—

Diseases of oesophagus, stomach and duodenum

5294

26943

1.21

33.47

4.9

3.7

—

Other abnormal uterine and vaginal bleeding

1133

5517

1.52

33.47

5.0

3.8

—

Demyelinating diseases of the central nervous system

457

2537

1.92

33.40

7.0

3.4

—

Seropositive rheumatoid arthritis

1162

8034

1.49

33.24

5.5

3.8

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

399

2127

2.01

33.21

6.6

4.2

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

226

973

2.55

33.18

5.1

3.8

—

Implicit bacterial Sepsis

1662

11210

1.39

33.08

7.4

3.8

—

Other complications of surgical and medical care, not elsewhere classified

486

2759

1.87

32.90

5.9

3.6

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

490

2782

1.85

32.80

5.8

4.0

—

Poor fetal growth

707

4445

1.68

32.76

3.8

3.1

—

Conduction disorders

1257

7328

1.47

32.72

4.9

3.8

—

Asthma, including avohilmo

6036

29759

1.19

32.72

4.2

3.7

—

Noninflammatory disorders of female genital tract

2476

9598

1.33

32.70

4.0

3.4

—

Unspecified fall

2204

16819

1.33

32.57

5.1

3.9

—

Endometriosis ASRM stages 1,2

906

6026

1.57

32.35

4.3

3.5

—

Substance abuse

2646

19922

1.29

32.13

4.3

3.7

—

Heterophoria

434

2405

1.92

32.04

4.7

3.6

—

Gonarthrosis

2967

13482

1.28

31.77

4.4

3.6

—

Alcohol use disorder, ICD-based

1829

13761

1.36

31.72

4.3

3.7

—

Orchitis and epididymitis

382

2027

1.98

31.67

6.0

3.3

—

Acute pancreatitis

838

5501

1.58

31.46

5.0

3.9

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2260

11886

1.32

31.34

4.7

4.0

—

Hernia of abdominal wall

1966

14982

1.34

31.27

5.1

3.9

—

Acute alcohol intoxication, ICD10

894

5962

1.55

31.23

4.3

3.6

—

Benign paroxysmal vertigo

1263

9001

1.45

31.20

5.2

4.2

—

Suicide or other Intentional self-harm

1174

8256

1.47

31.18

4.5

3.5

—

Crohn disease (strict definition, all UC cases excluded)

286

1391

2.23

31.16

4.3

3.5

—

Convulsions, not elsewhere classified

1076

7339

1.49

31.15

4.9

3.2

—

Alcohol use disorder, Swedish definition

2462

17911

1.30

31.13

4.4

3.7

—

L04AC Interleukin inhibitors

268

1273

2.29

31.04

4.3

3.5

—

Diseases of the respiratory system

3614

14674

1.25

30.98

4.2

3.2

—

Dental pulpitis 3, only avohilmo

794

3753

1.62

30.93

3.7

3.0

—

Aortic aneurysm

970

6473

1.52

30.82

4.8

4.0

—

Urticaria and erythema

1718

12876

1.37

30.80

4.7

3.7

—

Preterm labour and delivery

1214

8613

1.46

30.77

3.7

3.6

—

All anxiety disorders

3040

19651

1.27

30.72

4.3

3.4

—

Other psoriatic arthropathies

492

2861

1.82

30.64

4.3

3.7

—

Papulosquamous disorders

1728

12970

1.37

30.63

4.4

3.9

—

Other headache syndromes

1975

15114

1.34

30.41

4.8

3.6

—

Viral infections characterized by skin and mucous membrane lesions

1859

14115

1.35

30.20

5.4

3.8

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1740

10159

1.37

30.13

4.4

4.0

—

Unspecified mental disorder

1913

14595

1.34

30.10

4.4

3.6

—

MS-disease / Multiple Sclerosis

391

2139

1.95

30.08

7.4

3.3

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

430

2412

1.88

30.07

5.6

4.0

—

Other and unspecified vasculitis limited to skin

150

561

3.04

30.02

7.2

3.7

—

Faecal incontinence

432

2437

1.88

29.92

6.4

3.7

—

Abnormal results of function studies

420

2351

1.90

29.90

4.9

3.8

—

Emotional disorders starting during childhood or adolecense, excluding more controls

311

1551

2.12

29.81

4.2

2.7

—

Leiomyoma of uterus

2114

9116

1.33

29.79

4.2

3.6

—

Erysipelas

2360

16875

1.30

29.78

5.4

3.7

—

Other diseases of spinal cord

183

757

2.69

29.66

9.9

3.8

—

Carcinoma in situ of skin of other and unspecified parts of face

332

1727

2.05

29.64

6.3

4.5

—

Actinic keratosis

1544

10869

1.39

29.61

5.6

4.5

—

Anti-inflammatory and antirheumatic products, non-steroids

1579

5793

1.40

29.60

3.7

3.9

—

Impotence

241

1118

2.31

29.35

5.0

3.3

—

Other and unspecified effects of external causes

1297

9398

1.42

29.01

4.5

3.6

—

Skin changes due to chronic exposure to nonionizing radiation

1583

11180

1.38

29.01

5.6

4.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2761

20504

1.27

29.00

5.3

4.0

—

Maternal care for known or suspected malpresentation of fetus

906

4550

1.54

28.96

3.2

3.0

—

Disorders resulting from impaired renal tubular function

200

871

2.54

28.92

18.0

3.6

—

1679

11900

1.36

28.86

5.5

4.4

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

612

3818

1.67

28.86

4.8

3.9

—

Dental pulpitis 3

831

3972

1.57

28.75

3.7

3.0

—

Psoriatic arthropathies, ICD10

496

2945

1.77

28.65

4.3

3.8

—

Pain and other conditions associated with female genital organs and menstrual cycle

1066

7177

1.47

28.59

3.9

3.1

—

Irritable bowel syndrome

1318

9599

1.41

28.56

5.2

3.5

—

Female genital prolapse

1359

5663

1.42

28.37

4.7

3.8

—

Carcinoma in situ, bladder

167

675

2.75

28.34

6.1

3.5

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1952

15041

1.32

28.32

4.3

3.7

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2000

10537

1.33

28.31

4.8

4.1

—

Other viral diseases

1374

10057

1.40

28.30

5.2

3.5

—

Other diseases of pericardium

227

1048

2.35

28.24

6.4

3.5

—

Carcinoma in situ of other and unspecified sites

176

730

2.66

28.20

6.1

3.5

—

Radiculopathy

758

4993

1.58

28.18

5.0

3.8

—

Medical treatment for female infertility

1061

7457

1.47

28.18

3.2

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2747

22018

1.27

28.17

5.4

3.8

—

Asthma (diagnoses ohter than nonallergic)

4215

30207

1.21

28.07

4.5

3.7

—

Other anxiety disorders

2274

15865

1.30

27.93

4.4

3.3

—

Other demyelinating diseases of the central nervous system

223

1031

2.37

27.91

6.8

3.3

—

Calculus of kidney and ureter

1277

9289

1.41

27.84

5.1

3.9

—

Vasculitis limited to skin, not elsewhere classified

158

633

2.81

27.56

7.2

3.7

—

Problems related to lifestyle

515

3119

1.73

27.52

4.6

3.2

—

Substance use, excluding alcohol

887

6063

1.51

27.46

4.5

3.5

—

Dentofacial anomalies [including malocclusion]

1301

9410

1.40

27.36

4.4

3.3

—

Hypokalaemia

530

3246

1.71

27.14

6.5

3.9

—

Other and unspecified glaucoma

316

1670

2.02

27.02

5.0

4.5

—

GI-bleeding

1338

9848

1.39

26.99

5.6

4.1

—

Appendectomy

3085

24305

1.24

26.93

4.1

3.7

—

Iridocyclitis

1006

7075

1.47

26.82

4.7

3.9

—

Other CVD

795

5345

1.54

26.80

6.5

4.3

—

Other diseases of the digestive system

1334

9828

1.39

26.78

5.6

4.1

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

543

3353

1.69

26.73

4.7

4.0

—

Disorders of sclera, cornea, iris and ciliary body

2425

19363

1.28

26.67

4.5

3.9

—

Type 1 diabetes, wide definition, subgroup 1

959

6681

1.48

26.63

6.0

3.5

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

358

1978

1.92

26.61

4.2

3.4

—

Personality disorders

1312

9662

1.40

26.59

4.5

3.4

—

Infections of the skin and subcutaneous tissue

2595

20801

1.26

26.45

5.0

3.7

—

Gonarthrosis, primary, with knee surgery

2371

15397

1.28

26.44

4.8

4.2

—

Other diseases of anus and rectum

1309

9635

1.39

26.32

5.2

3.8

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1945

10351

1.32

26.25

4.8

4.1

—

Fibromyalgia

431

2525

1.80

26.18

5.0

3.2

—

Other disorders involving the immune mechanism, not elsewhere classified

176

757

2.57

26.16

12.5

3.5

—

Hypotension

678

4434

1.59

26.11

6.6

4.4

—

Pregnancy hypertension

2017

14235

1.31

26.04

3.9

3.5

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1912

10191

1.32

26.04

4.8

4.1

—

Urethral stricture

261

1307

2.13

26.04

7.3

3.3

—

Lung diseases due to external agents

577

3638

1.65

26.03

5.3

4.1

—

Testicular hypofunction

159

652

2.66

25.97

4.0

3.5

—

Etanercept

317

1702

1.99

25.97

5.2

3.6

—

Symptoms and signs concerning food and fluid intake

467

2795

1.75

25.96

5.7

3.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2180

17119

1.29

25.79

4.6

3.6

—

Ovarian cyst

1971

8835

1.32

25.77

4.4

3.4

—

Acute pancreatitis (for exclusion)

838

5739

1.51

25.75

5.0

4.0

—

Seronegative rheumatoid arthritis

548

3429

1.67

25.71

5.9

3.8

—

Maternal care for cervical incompetence

240

1185

2.22

25.55

4.7

3.8

—

AV-block

719

4328

1.56

25.44

5.0

3.9

—

Emotional disorders starting during childhood or adolescence

312

1673

1.99

25.25

4.2

3.1

—

Secondary polycythaemia

135

523

2.89

25.12

4.6

3.5

—

Adenomyosis (Endometriosis of uterus)

609

3928

1.61

25.06

4.6

3.9

—

Injury, poisoning and certain other consequences of external causes

3125

12795

1.24

24.95

4.0

3.3

—

Thoracic aortic aneurysm

575

3668

1.64

24.93

4.4

3.9

—

Osteoporosis

1062

7279

1.43

24.91

6.8

4.5

—

COPD (mode)

1314

7717

1.38

24.87

4.8

3.6

—

Other dialysis

163

695

2.59

24.73

20.0

3.7

—

Disorders of refraction and accommodation

1215

8909

1.40

24.72

4.8

3.6

—

Testicular dysfunction

171

741

2.50

24.69

3.9

3.4

—

Arthrosis

3300

14941

1.23

24.67

4.2

3.5

—

Mental and behavioural disorders due to opioids

209

987

2.29

24.65

5.3

3.2

—

Dementia in Alzheimer disease

692

3911

1.56

24.64

5.0

4.8

—

Other and unspecified nonorganic psychotic disorders

893

6251

1.47

24.45

4.1

3.5

—

Postpartum haemorrhage

1261

8129

1.39

24.40

3.2

3.3

—

Use of trihexyphenidyl

14.32

24.35

6.7

2.8

—

Leiomyoma of uterus

2779

12830

1.25

24.35

4.2

4.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1143

8363

1.41

24.22

5.6

4.1

—

Clear cell adenocarcinoma of kidney

226

1110

2.21

24.22

5.1

3.9

—

Other degenerative diseases of the nervous system

1207

6706

1.40

24.17

5.8

3.6

—

Disorders of adult personality and behaviour

1365

10268

1.36

24.07

4.4

3.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

163

704

2.56

24.05

12.7

3.6

—

Simple and mucopurulent chronic bronchitis

211

1007

2.24

24.01

4.9

4.2

—

Other obstructive and reflux uropathy

244

1235

2.13

23.94

6.8

3.1

—

Acute and subacute iridocyclitis

843

5866

1.48

23.91

4.8

3.8

—

Hypopituitarism

312

1707

1.93

23.90

4.6

3.5

—

Psoriasis (vulgaris), strict definition

173

768

2.47

23.86

4.6

3.5

—

Pre-eclampsia

966

6897

1.45

23.86

4.1

3.4

—

Universal erythroderma, KELA reimbursement

320

3.45

23.76

5.2

3.7

—

Non-follicular lymphoma, hilmo, excluding all cancers

377

2184

1.81

23.75

4.8

3.9

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2212

15485

1.28

23.75

3.9

3.6

—

Injuries to the neck

1037

7494

1.42

23.72

4.5

3.6

—

Nonalcoholic fatty liver disease

409

2429

1.77

23.68

4.0

3.8

—

Iron deficiency anaemia secondary to blood loss (chronic)

685

4588

1.55

23.65

5.6

4.1

—

Other and unspecified diseases of blood and blood-forming organs

143

588

2.71

23.57

4.7

3.8

—

Other dorsopathies, not elsewhere classified

5309

24139

1.17

23.48

4.5

3.5

—

Mixed and other personality disorders

400

2373

1.78

23.32

4.9

3.4

—

Propionic acid derivatives

1527

5792

1.35

23.20

3.8

3.9

—

Enlarged lymph nodes

694

4676

1.53

23.17

4.4

3.3

—

Other and unspecified drugs and medicaments

394

2335

1.78

23.14

5.4

3.9

—

Hyperkalaemia

249

1282

2.07

23.09

9.1

3.8

—

Other/unspecified seropositive rheumatoid arthritis

1152

8504

1.39

23.08

5.6

4.1

—

Emotional disorders and disorders of social functioning with onset specific to childhood

321

1775

1.91

23.08

4.3

3.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1712

13260

1.31

23.04

5.5

3.9

—

Inflammatory diseases of female pelvic organs

3043

18994

1.23

23.03

4.7

3.7

—

Ventral hernia

1027

7452

1.42

22.93

5.6

4.1

—

Malnutrition

119

455

2.95

22.86

6.4

4.1

—

Seropositive rheumatoid arthritis, wide

1162

8604

1.39

22.83

5.5

4.1

—

Disorders of eyelid, lacrimal system and orbit

3871

25717

1.20

22.72

4.9

3.8

—

Carcinoma in situ of skin of other and unspecified parts of face

332

1884

1.86

22.71

6.3

4.6

—

Psoriasis vulgaris

797

5545

1.48

22.66

4.4

3.8

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

753

5093

1.50

22.66

6.7

4.3

—

Malignant neoplasm of skin

2554

15661

1.25

22.65

4.8

4.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2514

20518

1.25

22.61

5.5

3.9

—

Urticaria

1368

10395

1.35

22.52

4.5

3.7

—

Impingement syndrome of shoulder

495

7702

0.63

22.45

4.4

3.6

—

Migraine

2339

16101

1.26

22.42

4.1

3.4

—

Type 1 diabetes, wide definition

987

7127

1.42

22.40

6.0

3.5

—

Noninfectious colitis NAS

596

3926

1.58

22.34

5.6

3.9

—

Coxarthrosis

2106

11382

1.28

22.32

4.7

3.7

—

Non-ischemic cardiomyopathy

1227

7513

1.37

22.30

5.9

4.0

—

Valvular operations

583

3822

1.58

22.21

4.3

3.8

—

Diverticular disease of intestine

3066

16902

1.22

22.01

5.0

3.7

—

Phlebitis and thrombophlebitis (not including DVT)

936

6733

1.43

22.00

5.3

3.8

—

Other menopausal disorders

1168

4948

1.39

21.99

3.9

3.7

—

Anterior Iridocyclitis

878

6253

1.45

21.94

4.9

3.9

—

Injuries to the thorax

1866

14794

1.29

21.90

4.8

4.0

—

IgA nephropathy (IgA glomerulonephritis)

140

592

2.63

21.79

13.7

3.4

—

Primary_lymphoid and hematopoietic malignant neoplasms

976

7087

1.42

21.71

4.6

4.2

—

Other metabolic disorders

597

3962

1.57

21.69

4.8

3.5

—

Type 1 diabetes

1114

8242

1.38

21.65

5.8

3.5

—

Delirium, not induced by alcohol and other psychoactive substances

452

2811

1.67

21.64

6.7

4.4

—

Carcinoma in situ, bladder

167

765

2.40

21.56

6.1

4.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

411

2509

1.72

21.53

5.4

3.7

—

Other diseases of pancreas

324

1855

1.84

21.49

4.9

3.9

—

Other disorders of lacrimal gland

1457

11241

1.33

21.48

5.7

3.9

—

Carcinoma in situ of other and unspecified sites

176

825

2.33

21.40

6.1

4.0

—

Viral pneumonia

538

3500

1.60

21.35

6.3

3.6

—

Coxarthrosis [arthrosis of hip](FG)

2257

13194

1.26

21.33

4.8

3.7

—

Polyuria

900

6472

1.43

21.22

6.9

3.6

—

Dysphagia

976

7108

1.41

21.21

5.8

3.6

—

Chronic diseases of tonsils and adenoids

2923

22203

0.82

21.20

3.6

—

Ankylosing spondylitis

413

2533

1.70

21.10

4.5

3.5

—

Lower back pain or/and sciatica

5011

30177

1.16

21.09

4.8

3.7

—

Memory loss

100

2497

0.38

21.04

4.9

4.4

—

Disorders of parathyroid gland

846

5952

1.45

21.03

7.4

4.4

—

Special screening examination for neoplasms

1541

0.23

21.00

3.2

3.4

—

Total colectomy

212

1071

2.13

20.99

5.5

3.7

—

Total colectomy operation

212

1071

2.13

20.99

5.5

3.7

—

Explicit bacterial Sepsis

435

2705

1.68

20.96

6.2

3.6

—

Pre-eclampsia or eclampsia

1011

7434

1.40

20.94

4.1

3.5

—

Dislocation, sprain and strain of joints and ligaments of head

223

1148

2.09

20.91

4.7

3.3

—

Angina pectoris

2508

13866

1.24

20.90

5.0

4.0

—

Unspecified kidney failure

393

2385

1.72

20.89

9.1

3.8

—

Seropositive rheumatoid arthritis, strict definition

664

4539

1.52

20.89

5.0

4.0

—

Disorders of lacrimal system

1798

14290

1.28

20.85

5.5

4.0

—

Appendicitis, broad definition

3462

26803

1.20

20.81

3.8

3.7

—

Unspecified/other endometriosis

470

2989

1.64

20.78

4.4

3.1

—

Postpartum hemorraghe, all women as controls

1261

9554

1.35

20.75

3.2

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

208

1047

2.13

20.67

7.1

3.9

—

Diseases of middle ear and mastoid

2782

18921

1.22

20.66

4.1

3.6

—

Localized swelling, mass and lump of skin and subcutaneous tissue

740

10465

0.69

20.57

4.6

3.9

—

Any event in hilmo or specialist outpatient

7.31

20.55

2.9

1.4

—

Streptococcal septicaemia

360

2147

1.76

20.55

6.5

3.7

—

Mental and behavioural disorders due to sedatives or hypnotics

318

1835

1.83

20.54

5.3

3.6

—

Other pleural conditions

407

2506

1.69

20.44

5.6

4.0

—

Diseases of appendix

3486

26962

1.19

20.37

3.8

3.7

—

Factors influencing health status and contact with health services

1697

6639

1.30

20.35

4.2

2.8

—

Protein-energy malnutrition of moderate and mild degree

200

4.09

20.28

6.3

4.3

—

Diabetic retinopathy, strict definition

762

4716

1.47

20.23

6.0

4.4

—

Disorders of vestibular function (Vertigo)

1944

15533

1.27

20.23

4.9

4.2

—

Female infertility, associated with anovulation

453

2880

1.65

20.21

3.5

2.8

—

Enteropathic arthropathies

134

574

2.57

20.19

5.5

3.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

322

1874

1.80

20.09

6.2

4.0

—

Acute appendicitis, no complications

2528

20846

1.23

20.08

3.7

—

Early onset COPD, excluding more controls

818

5836

1.44

20.02

4.8

3.3

—

Other specified disorders of kidney and ureter

176

848

2.26

19.96

7.1

3.7

—

Diabetic retinopathy, excluding more controls

1159

4880

1.38

19.93

5.8

4.0

—

Other and unspecified disorders of white blood cells

204

1037

2.12

19.91

4.8

3.8

—

Undetermined asthma, excluding more controls

549

3638

1.56

19.88

5.3

3.2

—

Personal history of certain other diseases

133

576

2.60

19.88

4.3

2.9

—

Optic neuritis

224

1178

2.04

19.78

7.0

3.4

—

Malignant neoplasm of urinary organs

404

2510

1.68

19.70

5.7

4.2

—

Acute and transient psychotic disorders

520

3422

1.58

19.65

4.5

3.6

—

Correction of physiology of bite - demanding therapy visit

339

2023

1.77

19.51

4.7

3.5

—

Brachial plexus disorders

431

2729

1.65

19.44

4.2

3.4

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1011

7257

1.38

19.39

4.6

4.1

—

Other secondary gonarthrosis

242

1313

1.96

19.33

5.3

3.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2200

14181

1.24

19.30

4.8

4.3

—

Oxicams

1080

4547

1.38

19.27

4.0

4.1

—

Gestational [pregnancy-induced] hypertension

1224

9354

1.34

19.23

3.6

3.3

—

Benign neoplasms

3862

18686

1.18

19.22

4.1

3.3

—

Acute alcohol intoxication

1072

8049

1.36

19.19

4.4

3.7

—

Benign neoplasm of other and unspecified endocrine glands

506

3328

1.58

19.18

4.5

3.8

—

Carcinoma in situ of prostate

109

5.25

19.13

6.0

2.7

—

Other/unspecified mastoiditis and related conditions

101

5.53

19.12

4.5

3.8

—

malignant neoplasm of female genital organs

630

4342

1.51

19.11

6.8

4.6

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

993

6713

1.38

19.07

3.7

3.1

—

Monoarthritis, not elsewhere classified

212

1107

2.04

19.00

4.5

3.4

—

Bacterial pneumonia, not elsewhere classified

985

11658

0.73

18.96

5.5

3.7

—

Dental caries 3 and operation codes, only avohilmo

1566

6146

1.31

18.84

3.7

4.0

—

Ulcerative enterocolitis

169

819

2.23

18.80

4.8

3.5

—

Undetermined asthma

549

3684

1.54

18.76

5.3

3.3

—

Other (seronegative) rheumatoid arthritis, wide

810

5856

1.42

18.67

5.9

4.1

—

Pain, not elsewhere classified

1145

8711

1.34

18.67

5.6

3.3

—

Cholangitis (primary sclerosing, PSC)

269

1522

1.87

18.65

6.0

3.9

—

Abnormal weight loss

380

2362

1.69

18.62

5.1

4.1

—

Fluid overload

7.48

18.60

15.1

3.7

—

Abnormal findings on diagnostic imaging of other body structures

539

3622

1.55

18.57

5.6

4.1

—

Pneumonia due to Haemophilus influenzae

6.88

18.55

5.7

3.7

—

Thyrotoxicosis, other and/or unspecified

851

6207

1.41

18.54

3.9

—

Osteopathies and chondropathies

2338

18338

1.23

18.50

5.8

3.9

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

699

4926

1.46

18.48

4.5

4.1

—

Arthropathies in other diseases classified elsewhere

174

860

2.17

18.29

6.7

3.4

—

Disorders of calcium metabolism

283

1638

1.83

18.24

6.3

3.7

—

Weight loss

417

2663

1.64

18.23

5.3

4.1

—

Other and unspecified psoriasis

295

1727

1.80

18.22

5.2

3.8

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

150

702

2.31

18.21

3.3

3.2

—

Iron deficiency

141

651

2.41

18.14

3.9

3.1

—

Malignant neoplasm of kidney, except renal pelvis

368

2285

1.68

18.05

5.5

4.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

538

3637

1.53

17.98

4.7

3.5

—

Other noninflammatory disorders of uterus, except cervix

917

4608

1.39

17.75

5.0

4.0

—

Hypertrophy of breast

761

5495

1.43

17.75

4.1

3.7

—

UC patients in KELA-register (code 208), prior to 1994

208

1106

2.01

17.73

4.5

3.8

—

Specific personality disorders

1097

8376

1.34

17.63

4.6

3.4

—

Benign leiomyoma with endometriosis

630

4405

1.48

17.60

4.8

4.1

—

Malignant neoplasm of digestive organs

1472

11483

1.29

17.49

4.3

—

Dental caries 1 and operation codes, only avohilmo

1323

5138

1.32

17.40

3.8

4.1

—

Female infertility

1549

7580

1.29

17.38

3.5

3.2

—

Striking against or struck by other objects

1363

10708

1.30

17.38

4.0

3.6

—

Pneumocystosis

369

2.88

17.35

6.8

3.5

—

Eustachian salpingitis and obstruction

358

2235

1.67

17.17

3.5

3.2

—

Herpesviral [herpes simplex] infections

504

3402

1.54

17.02

5.1

3.8

—

Spirochaetal infections, other/unspecified

102

2305

0.42

16.91

5.2

4.0

—

Acute suppurative otitis media

1262

9202

1.31

16.90

4.0

3.2

—

Abnormal findings on antenatal screening of mother

429

2808

1.60

16.90

3.8

2.8

—

Dislocation, sprain and strain of joints and ligaments at neck level

693

4970

1.44

16.87

4.0

3.4

—

Menorrhagia

1662

7359

1.27

16.69

4.0

3.5

—

Inflammatory disease of uterus

676

4842

1.44

16.66

4.9

3.4

—

Suppurative and unspecified otitis media

1733

12461

1.25

16.60

4.1

3.4

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

183

954

2.04

16.55

4.9

3.8

—

Diffuse large B-cell lymphoma, helper endpoint

183

954

2.04

16.55

4.9

3.8

—

Adverse effects, not elsewhere classified

870

6491

1.38

16.51

4.7

3.6

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

312

1632

1.72

16.50

5.1

4.0

—

Alcohol dependence

1065

8172

1.33

16.40

4.4

3.8

—

Abnormal serum enzyme levels

671

9150

0.71

16.35

4.7

3.9

—

Opening and dilatation of root channel of tooth

1835

0.37

16.34

3.8

3.6

—

Hypertrophy of breast in women and men

841

6254

1.38

16.30

4.1

3.7

—

Excessive, frequent and irregular menstruation

2046

9347

1.24

16.29

4.1

3.4

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

293

3.05

16.25

6.0

3.9

—

Gonarthrosis,primary

3784

20629

1.17

16.18

4.5

4.0

—

Fracture of rib(s), sternum and thoracic spine

1150

8941

1.31

16.09

4.8

4.1

—

Other juvenile arthritis

221

1238

1.90

16.05

4.7

3.1

—

Wet age-related macular degeneration

638

4462

1.44

16.02

5.1

4.8

—

Chronic sinusitis

1934

15941

1.23

16.00

4.5

3.7

—

Myeloproliferative diseases

347

2191

1.66

15.99

4.4

4.1

—

Other specific joint derangements/joint disorders

3482

20150

1.17

15.95

4.4

3.4

—

Other disorders of veins

1591

12856

1.26

15.94

4.8

3.9

—

1919

0.39

15.90

4.2

4.0

—

Post-traumatic stress disorder

429

2854

1.57

15.73

4.9

3.0

—

Other chronic obstructive pulmonary disease, including avohilmo

2116

14637

1.22

15.64

4.8

4.2

—

Ankylosing spondylitis, ICD10

388

2526

1.60

15.61

4.7

3.6

—

Secondary malignant neoplasm of other and unspecified sites

318

2.94

15.60

3.5

3.9

—

Polycystic ovarian syndrome, consortium definition

3566

18632

1.17

15.53

4.5

3.7

—

Acute appendicitis

3165

25732

1.17

15.51

3.8

3.7

—

Mumps

131

621

2.28

15.49

3.4

3.5

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

361

2312

1.62

15.47

4.6

4.0

—

Disorders of magnesium metabolism

173

3.86

15.46

5.6

3.4

—

Secondary uncertain malignant neoplasm

497

3410

1.51

15.44

4.0

4.2

—

Diabetic retinopathy

1367

6849

1.29

15.43

5.6

4.6

—

Calcific aortic valvular stenosis, including rheumatic fever

1126

8584

1.31

15.41

5.1

4.5

—

Degenerative macular diseases

488

3341

1.51

15.39

4.6

4.4

—

Carcinoma in situ of prostate

129

4.39

15.36

6.0

3.8

—

Operations 2 for CAVS

1121

8556

1.31

15.31

5.1

4.5

—

Calcific aortic valvular stenosis, diagnosis (helper)

1121

8556

1.31

15.31

5.1

4.5

—

Calcific aortic valvular stenosis, operated

1122

8569

1.31

15.25

5.1

4.5

—

Calcific aortic valvular stenosis

1122

8569

1.31

15.25

5.1

4.5

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

349

2226

1.63

15.23

4.6

3.9

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

220

1249

1.86

15.19

4.3

3.5

—

Injuries to the ankle and foot

3150

24754

1.17

15.19

4.0

3.6

—

Juvenile arthritis (FINNGEN)

244

1429

1.80

15.19

4.9

3.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1385

11100

1.27

15.14

4.3

3.9

—

Other appendicitis

367

2379

1.60

15.06

3.8

—

Other disorders of nervous system

282

1721

1.72

15.00

6.2

3.9

—

Use of pramipexole

859

6491

1.36

14.98

5.6

4.2

—

Diseases of arteries, arterioles and capillaries

2726

17343

1.19

14.93

5.5

4.1

—

Need for other prophylactic measures

1381

0.31

14.91

4.1

3.9

—

STROKE

2420

14163

1.20

14.88

5.0

3.6

—

Hypoparathyroidism

169

893

2.03

14.86

5.3

4.3

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1778

9515

1.24

14.85

4.2

3.9

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1778

9517

1.24

14.81

4.2

3.9

—

Cellulitis

871

6608

1.35

14.72

5.6

3.7

—

Redundant prepuce, phimosis and paraphimosis

677

4908

1.40

14.72

4.5

3.2

—

Other and unspecified myopathies

340

2182

1.62

14.61

5.1

4.1

—

Follow-up care involving plastic surgery

1064

0.23

14.61

3.5

3.6

—

Other abnormal findings of blood chemistry

203

1143

1.89

14.58

4.1

3.8

—

Schizophrenia

660

4808

1.41

14.58

4.5

3.6

—

Congenital malformations, deformations and chromosomal abnormalities

2701

22156

1.18

14.49

4.5

3.5

—

Myeloproliferative diseases (CML excluded)

316

2001

1.65

14.46

4.4

4.1

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

122

582

2.29

14.40

3.4

2.9

—

Sarcoidosis

537

3792

1.46

14.35

4.6

3.9

—

Maltreatment syndromes

255

1536

1.75

14.32

4.0

3.2

—

Emphysema

280

1725

1.69

14.25

5.1

3.9

—

Acute drug-induced interstitial lung disorder

176

3.64

14.24

4.7

4.1

—

Other embolism and thrombosis

512

3589

1.47

14.22

5.7

3.9

—

Carcinoma in situ of skin, other sites/unspecified

245

3.09

14.20

8.4

3.7

—

Cystic kidney disease

153

795

2.06

14.14

13.9

3.7

—

Non-follicular lymphoma

377

2495

1.57

14.13

4.8

4.2

—

Superficial injury of abdomen, lower back and pelvis

639

4663

1.41

14.06

5.1

3.7

—

Assault

547

3887

1.45

14.05

4.3

3.4

—

Endometriosis of ovary

733

5451

1.37

13.99

4.1

3.5

—

Use of fingolimod

237

3.14

13.95

11.4

2.8

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

877

6715

1.34

13.94

5.6

4.2

—

Acute pharyngitis

642

4661

1.40

13.88

3.9

3.0

—

Other ill-defined and unspecified causes of mortality

244

1463

1.75

13.88

4.9

4.2

—

Secondary lactase deficiency

10.52

13.87

7.9

2.9

—

Biological medicines for asthma

318

2.78

13.87

3.8

3.4

—

Triptan medication for migraine, single purchase ok

3666

21736

1.15

13.83

3.7

3.6

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

3666

21736

1.15

13.83

3.7

3.6

—

Disorders of optic nerve and visual pathways

409

2767

1.53

13.81

6.1

3.7

—

Ankylosing spondylitis, strict definition

200

1138

1.85

13.77

4.5

3.4

—

Other pulmonary heart/vessel disease

195

1102

1.87

13.76

5.9

4.2

—

Strabismus

1119

8838

1.29

13.72

4.7

3.7

—

Other coagulation defects

319

2051

1.62

13.72

5.3

3.7

—

Viral pneumonia (unknown virus, not influenza)

288

1807

1.67

13.71

6.7

3.6

—

Other diseases of intestine

474

3300

1.48

13.69

5.8

3.8

—

Secondary right heart disease

176

967

1.93

13.64

5.8

4.0

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1236

8006

1.28

13.63

4.2

4.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

662

4721

1.39

13.61

6.5

3.7

—

Asthma-related pneumonia

1432

11636

1.25

13.60

5.5

4.0

—

Excessive attrition of teeth

1999

9056

1.22

13.59

4.4

3.5

—

Pneumonia due to other infectious organisms, not elsewhere classified

150

785

2.04

13.58

5.6

3.4

—

Asthma, hospital admissions 3, pneumonia

1435

11666

1.25

13.56

5.4

4.0

—

Asthma-related pneumonia or sepsis

1435

11666

1.25

13.56

5.4

4.0

—

Benign neoplasm of middle ear and respiratory system

291

1832

1.65

13.52

3.8

—

Diseases of the myoneural junction and muscle

462

3210

1.49

13.52

5.3

4.1

—

Other and unspecified disorders of skin and subcutaneous tissue

1801

0.42

13.51

6.1

3.8

—

Umbilical hernia

1065

8394

1.29

13.49

4.9

3.8

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

936

3972

1.33

13.48

4.3

—

Chorioretinal inflammation

138

705

2.10

13.44

5.3

3.6

—

COPD

1764

12074

1.22

13.41

4.9

4.1

—

Colectomy operation

649

4786

1.39

13.40

5.3

4.2

—

Open wound of wrist and hand

1831

15139

1.21

13.33

3.9

3.6

—

Benign neoplasm: Pancreas

117

565

2.24

13.32

4.7

3.9

—

Fenamates

688

3421

1.39

13.28

4.0

3.9

—

Emotionally unstable personality disorder

590

4298

1.42

13.26

4.5

3.2

—

Cough

1696

13494

1.22

13.23

5.0

3.5

—

Unspecified chronic bronchitis

163

881

1.95

13.23

4.8

4.1

—

Nephrotic syndrome

145

757

2.05

13.23

14.0

3.4

—

Basal cell carcinoma

2179

14704

1.20

13.16

4.9

4.3

—

Vitreous haemorrhage

394

2673

1.53

13.11

6.7

4.0

—

Striae atrophicae

286

2.85

13.11

5.3

3.2

—

Artrosis, including avohilmo

3852

18592

1.15

13.10

4.0

3.7

—

Idiopathic pulmonary fibrosis

290

1843

1.64

13.08

5.4

4.3

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

333

2183

1.58

13.05

4.1

3.8

—

Assault by other specified means

234

3.06

13.04

4.8

3.2

—

Ill-defined and unknown causes of mortality

269

1680

1.67

13.04

4.9

4.2

—

Viral and other specified intestinal infections

970

7409

1.30

13.04

5.3

3.2

—

Hyperparathyroidism

701

5187

1.37

13.03

7.9

4.4

—

Congenital malformations of the urinary system

257

1590

1.69

13.03

11.5

3.6

—

Colorectal cancer

869

6707

1.32

13.02

4.5

4.3

—

Basal cell carcinoma, including avohilmo

2235

14953

1.19

12.99

4.9

4.3

—

Other necrotizing vasculopathies

287

1830

1.64

12.81

9.3

4.1

—

Transport accidents

2090

15693

1.20

12.77

4.0

3.4

—

Other female pelvic inflammatory diseases

700

5267

1.37

12.73

4.7

3.8

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3274

18937

0.87

12.67

4.5

3.3

—

Hyperaldosteronism

131

673

2.09

12.62

4.6

3.9

—

L02BX Other hormone antagonists and related agents

213

1270

1.77

12.56

4.4

3.9

—

Alzheimer’s disease (Atypical or mixed)

318

2074

1.58

12.53

5.1

4.9

—

Chronic viral hepatitis

233

1420

1.72

12.51

3.9

3.4

—

Asthma, hospital admissions , main diagnosis only

3805

30185

1.14

12.48

4.4

3.8

—

Protozoal diseases

130

669

2.09

12.48

6.5

3.7

—

Other disorders of skin and subcutaneous tissue

2874

22912

1.16

12.45

5.8

3.9

—

Coeliac disease

517

3724

1.43

12.43

4.7

3.8

—

Other viral diseases, not elsewhere classified

745

5653

1.34

12.42

5.7

3.6

—

Hydrocephalus in other diseases

133

3.89

12.41

6.1

3.7

—

Thyrotoxicosis

1039

8255

1.28

12.41

4.1

4.0

—

Disorders of iron metabolism

342

2.59

12.37

3.3

3.2

—

Complications following infusion, transfusion and therapeutic injection

367

2.53

12.36

5.2

3.5

—

Iridocyclitis in diseases classified elsewhere

443

2.37

12.35

5.5

3.7

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2257

18914

1.18

12.32

4.3

3.7

—

Other strabismus

925

7235

1.30

12.27

4.7

3.6

—

Arthropathy in Crohn disease

248

2.91

12.23

6.0

3.2

—

Other necrotizing vasculopathies (FG)

244

1516

1.68

12.15

9.4

3.8

—

Chronic tubulo-interstitial nephritis

165

921

1.89

12.13

9.7

3.3

—

Pregnancy with abortive outcome

3315

15192

1.15

12.10

4.1

3.8

—

Essential (haemorrhagic) thrombocythaemia

151

823

1.94

12.05

4.6

3.8

—

Diseases of peritoneum

399

2761

1.49

12.01

8.2

4.0

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

604

4482

1.38

11.97

4.6

4.0

—

Chronic myeloproliferative disease

286

2.72

11.94

4.9

3.9

—

Carcinoma in situ of cervix uteri

433

3055

1.47

11.89

3.5

3.2

—

Other benign neoplasm of uterus: Other parts/unspecified

176

1011

1.84

11.87

6.8

4.9

—

Benign neoplasm of other and unspecified endocrine glands

506

3662

1.42

11.87

4.5

4.0

—

Diseases of inner ear

2175

18233

1.18

11.86

4.8

4.1

—

Endometriosis of rectovaginal septum and vagina

343

2313

1.54

11.85

4.5

3.7

—

Family history of certain disabilities and chronic diseases leading to disablement

218

1328

1.72

11.83

3.2

3.1

—

Primary gonarthrosis, bilateral

1973

14655

1.19

11.80

4.9

4.2

—

Arthropathy in ulcerative colitis

306

2.64

11.79

5.2

3.3

—

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

5.45

11.79

5.0

4.5

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

426

2990

1.46

11.78

4.9

4.0

—

Salpingitis and oophoritis

727

5562

1.34

11.75

4.5

3.9

—

Other diseases of oesophagus

384

2649

1.50

11.75

5.7

3.9

—

Other viral hepatitis

266

1702

1.63

11.70

4.0

3.4

—

Other obstructed labour

336

2267

1.54

11.62

3.7

3.5

—

Keratitis

1428

11815

1.23

11.62

4.5

3.8

—

Postpartum hemorraghe, parous women as controls

1261

9024

1.25

11.61

3.2

—

Status post-ami

107

1715

0.50

11.60

5.7

4.1

—

Sequelae of other and unspecified infectious and parasitic diseases

226

1395

1.69

11.54

4.2

3.6

—

Psychotic depression

254

1611

1.64

11.53

4.4

3.3

—

Thyrotoxicosis with diffuse goitre

576

4276

1.38

11.48

4.0

3.7

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

367

2526

1.50

11.44

5.5

4.5

—

Abnormal blood-pressure reading, without diagnosis

194

1155

1.76

11.44

5.2

3.6

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

333

2250

1.54

11.41

4.1

3.1

—

Spontaneous abortion

2151

12523

1.18

11.37

3.6

—

Mental and behavioural disorders due to cannabinoids

139

752

1.95

11.37

3.9

3.3

—

Diabetic nephropathy, excluding more controls

598

3726

1.38

11.33

9.1

3.9

—

Malignant neoplasm of breast, HER2-negative

1926

12015

1.19

11.32

4.2

4.3

—

Polycystic ovarian syndrome, broad definition

581

4341

1.38

11.30

3.7

3.0

—

Dissociative [conversion] disorders

206

1255

1.74

11.30

5.2

3.1

—

ILD medications: nintedanib

136

3.67

11.27

3.1

3.4

—

Ulcerative proctitis

264

1703

1.62

11.26

4.3

3.5

—

Traumatic subdural haemorrhage

474

3360

1.42

11.24

5.2

3.7

—

Dental caries 2 and operation codes, only avohilmo

2778

19707

0.86

11.24

3.8

3.9

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

650

4922

1.35

11.22

4.3

4.1

—

Prolonged pregnancy

669

4641

1.35

11.19

2.8

3.1

—

Endocarditis

145

799

1.91

11.19

6.1

3.4

—

Injury of nerves and spinal cord at neck level

107

535

2.16

11.18

6.8

3.5

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

161

915

1.85

11.18

8.0

3.2

—

Superficial injuries involving multiple body regions

130

695

2.00

11.17

5.0

3.5

—

Disorders of tooth development and eruption

227

1376

1.67

11.15

5.8

3.0

—

Postmenopausal bleeding

1045

4573

1.28

11.15

4.8

4.0

—

Injuries involving multiple body regions

172

1000

1.82

11.15

4.7

3.6

—

Benign leiomyoma with endometriosis

630

4765

1.36

11.13

4.8

4.3

—

Ectopic pregnancy

740

5721

1.32

11.11

3.9

3.5

—

Bacterial pneumonia (organism specified)

1275

14086

0.81

11.10

5.5

4.0

—

Other specified/unspecified soft tissue disorders

212

1304

1.70

11.04

5.9

3.6

—

Irregular menses

2241

15676

1.17

11.03

4.2

3.5

—

Calculus of lower urinary tract

213

1313

1.70

11.02

6.2

3.7

—

Ascites

278

1822

1.58

11.01

7.3

3.5

—

Fitting and adjustment of external prosthetic device

5.02

10.91

10.1

3.6

—

Chronic periapical parodontitis

798

6239

1.30

10.90

6.6

3.6

—

Fungal Sepsis

158

905

1.85

10.80

8.8

3.5

—

Hypermetropia

297

1984

1.55

10.79

5.8

3.8

—

Other specified and unspecified personality disorders

398

2813

1.46

10.78

5.4

3.4

—

Bacterial pneumoniae

1142

12357

0.81

10.72

5.5

3.7

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

4.96

10.67

5.1

3.9

—

Other follicular disorders

298

1998

1.55

10.65

4.9

3.4

—

Macular pucker

538

4004

1.38

10.65

4.6

4.3

—

Disorders of lipoprotein metabolism and other lipidaemias

3403

18961

1.14

10.64

5.1

3.7

—

L01XE Protein kinase inhibitors

227

1437

1.65

10.60

4.4

4.1

—

Fissure and fistula of anal and rectal regions

979

7870

1.27

10.58

4.3

3.6

—

DVT of lower extremities

710

5492

1.32

10.57

5.3

3.9

—

Polycythaemia vera

133

728

1.93

10.51

4.5

3.8

—

Alcohol abuse, main dg, excluding more controls

575

4323

1.36

10.51

4.6

3.4

—

Cardiomyopathy

624

4744

1.34

10.50

4.3

3.7

—

Combinations of oral blood glucose lowering drugs

1040

8425

1.26

10.50

4.2

3.9

—

Multiple gestation

373

2616

1.47

10.49

3.3

3.2

—

Female infertility, cervigal, vaginal, other or unspecified origin

1313

7255

1.23

10.49

3.6

3.2

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

397

2811

1.45

10.48

6.0

4.3

—

Carcinoma in situ of skin

273

1802

1.57

10.47

6.0

4.2

—

Other sleep disorders

423

3034

1.43

10.46

4.5

3.6

—

Astigmatism

259

1692

1.59

10.44

5.7

3.6

—

Dermatitis due to substances taken internally

242

1560

1.62

10.43

6.1

3.6

—

Other abnormal products of conception

1512

8433

1.21

10.42

3.4

3.2

—

Use of rasagiline

117

621

2.03

10.38

5.9

4.1

—

Other chronic obstructive pulmonary disease

1664

11704

1.20

10.38

4.9

4.1

—

Other sexually transmitted chlamydial diseases

136

2369

0.55

10.37

3.6

3.0

—

Use of disulfiram, acamprosate or naltrexone

331

2278

1.50

10.31

4.1

3.6

—

Mental retardation, excluding more controls

153

862

1.83

10.30

5.7

3.4

—

Scabies

192

1175

1.71

10.28

4.5

3.6

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1266

10372

1.23

10.27

4.4

3.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

275

1825

1.56

10.27

8.0

3.4

—

Bipolar affective disorders

811

6409

1.29

10.23

4.5

3.3

—

Progressive vascular leukoencephalopathy

783

0.25

10.22

4.0

4.6

—

Hypertensive Renal Disease

133

733

1.90

10.21

9.6

3.6

—

Isolated proteinuria with specified morphological lesion

265

2.64

10.18

10.3

3.4

—

Hyperkinetic disorders, excluding more controls

450

3188

1.41

10.16

3.5

2.7

—

Malignant neoplasm of endocrine gland

289

1946

1.54

10.16

4.0

—

Ulcerative colitis (strict) with PSC

165

3.12

10.15

3.6

3.1

—

Disorders of adrenal gland, other and/or unspecified

113

3.76

10.14

4.8

3.0

—

Abnormal reflex

129

3.58

10.14

6.2

3.2

—

Superficial injury of hip and thigh

563

4244

1.36

10.13

5.7

4.1

—

Drug-induced osteoporosis with pathological fracture

354

2.39

10.12

7.6

4.1

—

Car occupant injured in other and unspecified transport accidents

799

6313

1.29

10.12

4.2

3.6

—

Viral hepatitis

296

2005

1.53

10.06

4.0

3.5

—

Malignant neoplasm of corpus uteri

321

2213

1.51

10.06

5.4

4.8

—

Hyperfunction of pituitary gland

223

1424

1.64

10.05

4.5

3.5

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

220

1401

1.64

10.04

4.3

3.8

—

IBD (strict) with PSC

200

2.87

10.02

3.7

3.0

—

Benign neoplasm: Adrenal gland

257

1692

1.57

10.00

4.5

3.7

—

Malignant neoplasm of breast

1968

12202

1.18

9.99

4.3

4.2

—

Infectious mononucleosis

405

2914

1.43

9.97

3.8

3.1

—

Benign neoplasms

4912

24877

1.11

9.95

4.2

3.5

—

Obstructed labour due to maternal pelvic abnormality

318

4560

0.68

9.94

4.1

3.9

—

Diffuse large B-cell lymphoma

183

1118

1.72

9.94

4.9

4.1

—

Benign neoplasm: Pancreas

117

630

1.99

9.94

4.7

4.1

—

Carcinoma in situ of skin, other sites/unspecified

294

2.54

9.93

8.4

4.2

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

422

2.22

9.89

4.3

3.2

—

Superficial injury of thorax

574

4357

1.35

9.89

5.3

3.9

—

Temporomandibular joint disorders, including avohilmo

1895

16294

1.18

9.82

4.1

3.5

—

Systemic sclerosis (FG)

110

582

2.02

9.79

6.4

3.4

—

Injuries to the shoulder and upper arm

3571

26813

1.13

9.78

4.4

3.9

—

Acute lymphadenitis

260

1727

1.56

9.78

4.5

3.5

—

Thyroiditis, ILD-related definition

469

3464

1.39

9.77

4.4

3.5

—

Cutaneous abscess, furuncle and carbuncle

1004

8170

1.25

9.75

5.2

3.6

—

Twin gestation

357

2520

1.46

9.73

3.3

3.2

—

Persons encountering health services in circumstances related to reproduction

2335

13787

1.16

9.67

3.5

3.6

—

Unspecified jaundice

195

1215

1.67

9.66

4.4

3.5

—

Monoamine oxidase A inhibitors

453

3332

1.39

9.64

4.8

3.7

—

Carcinoma in situ of cervix uteri

433

3174

1.41

9.62

3.5

3.3

—

Antepartum haemorrhage, not elsewhere classified

350

2469

1.46

9.60

3.3

3.1

—

Atrophic disorders of skin

572

4364

1.34

9.59

4.5

3.9

—

Nerve, nerve root and plexus disorders

4841

27650

1.11

9.56

4.5

3.8

—

Osteoporosis with pathological fracture (FG)

251

1663

1.57

9.54

7.6

4.3

—

Care involving use of rehabilitation procedures

2116

23062

0.86

9.51

4.7

3.6

—

Other crystal arthropathies

402

2.22

9.49

6.9

4.0

—

Carcinoid syndrome

232

2.72

9.46

3.7

3.6

—

Benign neoplasm: Endocrine pancreas

129

3.40

9.38

4.8

3.6

—

Other infective otitis externa

1650

0.50

9.38

4.7

3.7

—

Elevated blood glucose level

321

2241

1.48

9.38

5.2

3.9

—

Colitis, primary sclerosing, strict definition

244

2.62

9.35

3.7

2.9

—

Multiple delivery

306

2117

1.49

9.33

3.5

3.8

—

Wegener granulomatosis

379

2.26

9.33

12.5

3.7

—

Other fall from one level to another

883

7122

1.26

9.32

4.3

3.7

—

Anisometropia and aniseikonia

143

833

1.82

9.32

5.8

3.7

—

Carcinoma in situ of skin of trunk

110

591

1.97

9.30

7.4

3.8

—

Diabetic nephropathy

600

4572

1.33

9.28

9.1

4.4

—

Myocarditis

179

1101

1.68

9.27

4.4

2.9

—

Fracture of lumbar spine and pelvis

799

6374

1.28

9.24

5.9

4.3

—

Other inflammatory liver diseases

264

1781

1.54

9.24

5.3

3.9

—

Other benign neoplasm of uterus: Other parts/unspecified

176

1087

1.70

9.21

6.8

5.2

—

Carcinoma in situ of breast, other/unspecified

303

2.41

9.16

3.9

4.3

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

158

951

1.75

9.13

4.2

3.9

—

Use of antiglaucoma preparations and miotics

294

2028

1.50

9.12

5.3

4.6

—

Colitis, primary sclerosing

323

2.35

9.10

3.8

2.9

—

Intrahepatic Cholestasis of Pregnancy (ICP)

322

2266

1.47

9.10

3.4

3.1

—

Endometriosis ASRM stages 3,4

975

7984

1.24

9.04

4.1

3.8

—

Polyp of the female genital tract

1314

6390

1.21

9.04

4.3

3.7

—

Implicit fungal Sepsis

141

825

1.80

9.03

9.2

3.5

—

Contact with nonpowered hand tool

177

1098

1.68

9.03

3.4

3.7

—

Familial hypercholesterolemia

339

4723

0.70

9.01

5.3

3.9

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

352

2516

1.44

9.01

4.6

4.2

—

Respiratory disorders in diseases classified elsewhere

339

2.33

8.98

10.1

3.7

—

Visual field defects

324

2285

1.46

8.97

5.0

4.1

—

Chronic iridocyclitis

209

1351

1.61

8.97

5.2

3.8

—

Other abnormalities of plasma proteins

352

2.29

8.97

5.5

3.8

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

111

607

1.94

8.96

13.5

4.4

—

Anaemia in chronic diseases classified elsewhere

103

550

2.00

8.95

12.5

3.5

—

Zoster [herpes zoster]

658

5159

1.30

8.94

5.8

4.2

—

Orthopaedic devices associated with adverse incidents

425

0.20

8.92

4.1

4.3

—

Female infertility, tubal origin

200

1280

1.62

8.88

3.6

3.0

—

Nephropathy induced by unspecified drug, medicament or biological substance

17.18

8.86

8.7

4.8

—

Benign neoplasm: Colon

1514

17334

0.85

8.84

5.3

4.2

—

Abnormalities of gait and mobility

426

3153

1.39

8.81

6.2

4.0

—

COPD, hospital admissions

1687

12275

1.18

8.74

4.9

4.2

—

Other infectious diseases

299

2089

1.48

8.72

7.1

4.0

—

Other disorders of breast

284

4046

0.68

8.70

4.0

3.8

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

152

916

1.73

8.66

4.8

3.7

—

Follicular lymphoma

155

940

1.72

8.65

4.0

3.9

—

Other disorders of glucose regulation and pancreatic internal secretion

325

2308

1.45

8.65

6.2

3.8

—

Haemorrhage, not elsewhere classified

144

857

1.76

8.63

6.8

3.4

—

Crystal arthropathies, rheuma endpoint

418

2.13

8.59

6.9

3.7

—

Acidosis

481

2.05

8.59

8.6

3.5

—

Disorders of pituitary gland, other and/or unspecified

130

3.24

8.59

4.9

4.0

—

Other/unspecified cytomegaloviral diseases

425

2.12

8.59

15.1

3.7

—

Lupus erythematosus

113

631

1.91

8.58

7.2

3.8

—

Other gastritis (incl. Duodenitis)

883

7193

1.25

8.58

5.5

3.9

—

Peritonsillar abscess

912

7458

1.24

8.55

3.8

3.4

—

Spermatocele

255

1732

1.51

8.54

4.0

3.3

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

336

2407

1.44

8.52

4.6

4.2

—

Disorders of vitreous body

1837

15616

1.16

8.50

4.9

4.2

—

Cardiomyopathies, Primary/intrinsic

430

3202

1.37

8.49

4.0

3.7

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

531

1.98

8.47

5.8

3.6

—

Dronedarone medication

124

714

1.84

8.47

5.0

3.7

—

Abnormal findings on examination of urine, without diagnosis

183

1165

1.64

8.45

8.8

3.8

—

Otitis media, unspecified

499

3498

1.35

8.44

4.7

3.2

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

287

2.37

8.44

5.0

3.1

—

Any prescribed medicine buy

5.60

8.41

3.9

2.1

—

Melanoma in situ

147

887

1.74

8.41

4.6

4.0

—

Acute peritonitis

243

1645

1.53

8.39

9.9

3.9

—

Benign neoplasm: Choroid

205

1339

1.59

8.38

4.4

3.8

—

Colorectal adenocarcinoma

699

5566

1.28

8.37

4.5

4.3

—

Extrapyramidal and movement disorders

1382

11766

1.19

8.34

5.2

4.2

—

Calcific tendinitis of shoulder

227

1517

1.55

8.33

4.1

3.5

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

279

1944

1.48

8.28

4.1

3.8

—

Cholecystitis

500

3821

1.34

8.27

5.0

4.0

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

112

629

1.87

8.25

4.5

3.8

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

233

1568

1.53

8.25

5.5

4.0

—

Early onset COPD

818

6641

1.25

8.23

4.8

3.9

—

Family history of malignant neoplasm

402

2982

1.38

8.22

3.6

3.3

—

Bacterial, viral and other infectious agents

331

2380

1.43

8.22

4.9

3.6

—

Other shoulder lesions

362

2642

1.41

8.21

5.1

3.4

—

Cytomegaloviral disease

100

545

1.95

8.20

13.6

3.5

—

L02BG Aromatase inhibitors

1079

9014

1.22

8.17

4.4

—

Benign neoplasm: Skin, unspecified

150

916

1.71

8.17

4.8

3.5

—

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

109

611

1.89

8.15

5.2

3.7

—

Cytomegalovirus infection, IBD co-morbidity

525

1.97

8.15

13.8

3.5

—

Traumatic subarachnoid haemorrhage

134

795

1.76

8.12

4.9

3.3

—

Systemic sclerosis

110

620

1.88

8.11

6.4

3.7

—

Chronic gastritis

726

8999

0.80

8.08

5.7

4.1

—

Complications associated with artificial fertilization

514

1.98

8.03

2.9

2.7

—

Other and unspecified coagulation defects

203

1339

1.58

8.03

5.4

3.5

—

Childhood asthma (age<16), excluding more controls

671

4225

1.28

8.02

3.3

2.6

—

Childhood asthma (age<16)

671

4227

1.28

8.02

3.3

2.6

—

Polymyalgia rheumatica

474

3617

1.34

8.01

5.8

4.5

—

Other enthesopathies

1179

9938

1.20

8.01

4.1

3.6

—

Other benign neoplasms of connective and other soft tissue

350

2552

1.41

7.98

4.3

3.7

—

Other and unspecified urticaria

791

6425

1.25

7.97

4.3

3.6

—

D07AA Corticosteroids, weak (group I)

646

5125

1.28

7.97

4.5

3.5

—

Assault by unspecified means

507

1.97

7.96

4.3

3.3

—

Disorders of vitreous body and globe

1879

16018

1.16

7.95

4.9

4.2

—

Benign mammary dysplasia

325

4456

0.71

7.94

5.1

4.3

—

Complications predominantly related to the puerperium

1135

9556

1.21

7.92

3.8

3.4

—

Failure and rejection of transplanted organs and tissues

289

2.32

7.91

12.0

3.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

4337

27779

1.10

7.90

4.9

3.7

—

Cardiomyopathy (excluding other)

439

3318

1.35

7.88

4.0

3.7

—

Postprocedural disorders of nervous system

310

2226

1.44

7.84

5.1

3.4

—

Molar incisor enamel hypoplasia, with caries

102

3.30

7.83

15.5

2.7

—

Injuries to the hip and thigh

1803

14390

1.16

7.81

5.3

4.1

—

Pericarditis

141

858

1.72

7.80

6.7

3.4

—

Acute laryngitis and tracheitis

499

3783

1.32

7.80

3.6

3.0

—

Superficial injury of lower leg

992

8258

1.22

7.80

5.1

3.7

—

CR(E)ST syndrome

393

2.12

7.79

5.4

3.8

—

Folate deficiency anaemia

184

2.71

7.79

9.0

4.0

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

374

2766

1.38

7.77

4.3

4.1

—

Colonic or urogenital fistula

1040

8702

1.21

7.73

4.5

3.9

—

Pyogenic arthritis

241

1656

1.50

7.69

5.4

3.6

—

Diastasis of muscle

192

2.67

7.68

5.2

3.1

—

Disorders of parathyroid gland, other and/or unspecified

187

2.73

7.67

5.9

4.1

—

Drug-induced interstitial lung disorders, unspecified

5.55

7.64

4.9

3.4

—

Aortic valve malfunction, age under 60 years

331

2411

1.41

7.64

4.6

3.7

—

COPD, early/later onset

1684

12353

1.16

7.63

4.9

4.2

—

Systemic sclerosis, icd10

109

625

1.85

7.63

6.4

3.8

—

Isolated proteinuria

125

744

1.77

7.62

9.0

3.5

—

Long labour

1065

7806

1.21

7.58

3.3

—

Mental retardation

153

957

1.66

7.57

5.7

3.6

—

Artificial opening status

187

1226

1.58

7.56

9.2

3.5

—

TMD related pain

160

1018

1.65

7.52

5.5

3.4

—

Other benign neoplasms of uterus

201

1342

1.56

7.51

6.5

4.6

—

Necrotizing fasciitis

3.48

7.51

7.2

4.1

—

Atopic dermatitis, strict definition with reimbursement

1349

11215

1.18

7.48

4.0

3.2

—

Hard cardiovascular diseases

3169

18351

1.12

7.46

5.0

4.0

—

Nonorganic sleeping disorders, excluding more controls

716

5797

1.26

7.44

4.6

3.3

—

Sub-endpoint used in defining T1D endpoints

1170

9755

1.19

7.43

5.9

3.7

—

Intestinal adhesions without obstruction

306

2213

1.42

7.41

5.9

3.7

—

Pyoderma gangrenosum

171

2.75

7.40

6.7

3.3

—

Short Achilles tendon (acquired)

668

0.32

7.40

2.8

3.2

—

Open wound of forearm

360

2673

1.38

7.40

5.1

3.6

—

Fibrosis and cirrhosis of liver

265

1871

1.46

7.40

4.9

4.1

—

Septal defects

241

1635

1.49

7.39

3.9

3.7

—

Carcinoma in situ of breast, other/unspecified

332

2.19

7.37

3.9

4.4

—

Pediculosis, acariasis and other infestations

227

1559

1.51

7.36

4.8

3.6

—

Hernia

4070

25243

1.10

7.33

4.6

3.8

—

Abnormal findings in cerebrospinal fluid

4.22

7.33

5.5

3.4

—

Secondary thrombocytopenia

279

2.30

7.32

6.4

4.0

—

Carcinoma in situ of other and unspecified digestive organs

521

1.91

7.32

5.6

3.7

—

Sequelae of infectious and parasitic diseases

284

2031

1.44

7.32

4.5

3.9

—

Labour and delivery complicated by fetal stress [distress]

1157

6531

1.20

7.31

3.2

3.1

—

Other noninflammatory disorders of vulva and perineum

372

2782

1.37

7.29

5.1

3.4

—

Hydrocele

376

2812

1.36

7.24

4.8

3.4

—

Endometriosis diagnosis and infertility diagnosis occurring together

446

3430

1.33

7.21

4.0

3.3

—

Malignant melanoma

517

4050

1.30

7.21

4.5

4.2

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

112

656

1.79

7.18

4.6

3.6

—

Carcinoma in situ of colon

268

2.30

7.14

5.9

3.3

—

Other peripheral vertigo

342

2536

1.39

7.13

5.1

4.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

806

6642

1.23

7.13

3.8

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

205

2.52

7.10

5.1

4.3

—

Asthma/COPD (KELA code 203)

4426

28681

1.09

7.09

4.2

3.7

—

Noise effects on inner ear

996

0.45

7.09

3.7

—

Benign neoplasm of middle ear and respiratory system

291

2104

1.42

7.09

3.8

4.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1576

13710

1.16

7.07

3.8

3.4

—

Organic, including symptomatic, mental disorders

1816

11500

1.15

7.07

5.5

4.4

—

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

3.40

7.07

3.5

3.2

—

Pneumonitis due to solids and liquids

275

1968

1.43

7.07

5.5

4.0

—

Additional codes for the location of defect, injury or illness

1570

0.55

7.06

4.4

3.8

—

Disorders of synovium and tendon

2267

18194

1.13

7.05

4.1

3.5

—

Other neurological diseases

2910

21122

1.12

7.04

5.4

4.0

—

All influenza

929

7763

1.21

7.02

5.7

3.7

—

Seborrhoeic dermatitis

353

2636

1.37

7.00

5.8

3.7

—

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

232

2.39

6.97

3.6

3.2

—

Benign neoplasm: Larynx

113

669

1.76

6.97

4.0

3.5

—

Dental caries

966

8029

1.21

6.95

6.7

3.5

—

Benign neoplasm of eye and adnexa

335

2484

1.38

6.95

5.3

3.9

—

Malignant neoplasm of cervix uteri

395

2.04

6.95

5.7

3.7

—

Pure hypercholesterolaemia

2330

17501

0.89

6.93

5.0

3.7

—

Non-allergic asthma (mode), excluding more controls

752

6107

1.24

6.93

4.4

3.3

—

Restless leg syndrome

441

3406

1.32

6.91

4.3

4.0

—

Other disorders of penis

293

2126

1.41

6.90

5.0

3.3

—

Acute epiglottitis

353

2.08

6.89

4.4

3.0

—

Assault by bodily force

299

2182

1.41

6.89

3.8

3.3

—

Benign neoplasm of thyroid gland

125

764

1.71

6.88

4.7

3.8

—

Hidradenitis suppurativa

158

1025

1.61

6.83

4.9

3.2

—

Cardiomyopathy, other and unspecified

277

2000

1.42

6.79

4.5

3.7

—

Follicular adenocarcinoma of thyroid gland

148

2.80

6.78

4.0

3.9

—

Misadventures to patients during surgical and medical care

518

4092

1.29

6.78

5.8

3.8

—

Medicines for HER+ breast cancer

1334

11229

1.17

6.76

4.3

—

Cyst of kidney

244

1728

1.46

6.76

5.6

4.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1375

11906

1.17

6.75

4.5

3.4

—

Sudden idiopathic hearing loss

365

2756

1.36

6.74

4.9

4.0

—

Heartburn

378

2866

1.35

6.74

4.9

3.3

—

Bronchiectasis

286

2081

1.41

6.74

5.5

4.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

194

1313

1.52

6.74

4.3

3.8

—

Mental retardation, wide definition

157

1017

1.60

6.73

5.6

3.7

—

Erectile dysfunction

277

2005

1.42

6.73

4.8

4.0

—

Other/unspecified enthesopathies, not elsewhere classified

330

2455

1.38

6.72

4.9

3.6

—

Glaucoma-related operations

206

1417

1.51

6.71

4.0

4.5

—

Alcohol abuse, main dg

575

4602

1.27

6.70

4.6

3.6

—

Congenital malformations of cardiac septa

249

1711

1.45

6.70

3.9

3.7

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

351

2639

1.36

6.69

5.4

3.9

—

Later onset COPD, excluding more controls

762

4884

1.24

6.69

5.1

3.9

—

Graves disease, strict definition

389

2969

1.34

6.68

3.6

3.7

—

Diaphragmatic hernia

993

11719

0.84

6.67

4.9

4.1

—

Parodontitis or/and operation codes

2479

16406

0.89

6.67

4.6

3.9

—

Dementia in other diseases classified elsewhere

163

1069

1.58

6.66

7.4

4.2

—

Habitual aborter

103

605

1.80

6.66

4.6

2.8

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

480

3764

1.30

6.66

5.0

4.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

348

2613

1.36

6.66

4.6

3.7

—

Glaucoma secondary to other eye disorders

154

998

1.60

6.64

5.5

4.1

—

Postviral fatigue syndrome

212

2.45

6.64

3.9

3.0

—

Myopia

508

4017

1.29

6.61

4.3

3.4

—

Deforming dorsopathies

1126

9623

1.19

6.61

4.5

3.6

—

Benign neoplasm: Endocrine pancreas

157

2.75

6.60

4.8

4.0

—

Familial hypercholesterolemia, with ischemic heart disease

173

2557

0.66

6.58

6.1

4.1

—

Disturbance of activity and attention

434

3324

1.32

6.57

3.5

3.1

—

Deep endometriosis

400

3075

1.33

6.57

4.3

3.8

—

Other recurrent vertebral subluxation

6.27

6.55

13.6

3.1

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

351

2.04

6.55

3.4

3.1

—

Malignant neoplasm of colon

511

4048

1.29

6.54

4.3

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

260

1869

1.43

6.53

3.6

4.0

—

Hypoplasia of dental enamel, including avohilmo

126

2.83

6.48

15.6

3.2

—

Pustular psoriasis

178

1198

1.54

6.47

4.5

3.9

—

Ulcer of lower limb, not elsewhere classified

477

3753

1.30

6.46

8.3

4.1

—

Spinal stenosis

1970

13707

1.14

6.46

5.0

3.9

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

467

3663

1.30

6.45

4.6

4.0

—

Osteomyelitis of vertebra

3.69

6.44

10.9

3.5

—

Hodgkin lymphoma

112

678

1.73

6.43

4.4

3.3

—

Other specified and unspecified disorders of eye and adnexa

1012

0.48

6.43

4.2

3.8

—

Coxarthrosis, primary, with hip surgery

1713

14324

1.15

6.42

4.6

4.3

—

Carcinoma in situ of skin

273

1990

1.41

6.40

6.0

4.4

—

Contact with sharp glass

159

1048

1.58

6.39

4.0

3.3

—

Chronic Coagulation defects

109

659

1.74

6.36

4.2

3.4

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

104

619

1.76

6.36

5.5

4.0

—

Other overlap syndromes

480

1.88

6.35

6.0

3.5

—

Multiple myeloma and malignant plasma cell neoplasms

152

992

1.59

6.35

5.2

4.1

—

Generalized skin eruption due to drugs and medicaments

161

1067

1.57

6.34

6.4

3.7

—

Malignant neoplasm of thyroid gland

252

1816

1.43

6.34

4.1

4.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

302

2241

1.38

6.32

4.3

4.1

—

Vascular syndromes of brain in cerebrovascular disorders

1099

0.50

6.31

5.2

4.2

—

SLE (Finngen)

131

828

1.64

6.31

9.7

3.4

—

Rosacea

429

3346

1.31

6.29

4.6

3.8

—

Postmenopausal atrophic vaginitis

911

4596

1.21

6.28

5.3

4.0

—

Polyarthritis, unspecified

143

925

1.61

6.25

5.1

3.5

—

Malignant neoplasm of small intestine

489

1.86

6.25

4.7

4.0

—

Mental disorders, not otherwise specified

175

2553

0.67

6.25

3.9

3.5

—

Unspecified contracted kidney

124

2.88

6.25

13.2

3.6

—

Other bursopathies

479

3789

1.29

6.22

5.2

3.7

—

Other/unspecified rheumatoid arthritis

459

3614

1.30

6.22

6.9

4.3

—

severe traumatic brain injury, does not include concussion

762

6330

1.22

6.21

4.9

4.2

—

Pneumonia due to Streptococcus pneumoniae

162

1079

1.55

6.19

5.2

3.4

—

Kyphosis

319

2.09

6.18

5.7

3.7

—

Fracture of skull and facial bones

760

6316

1.22

6.17

4.3

3.6

—

Deposits [accretions] on teeth

249

1734

1.42

6.16

9.1

3.5

—

Postprocedural disorders of digestive system, not elsewhere classified

124

780

1.66

6.14

7.1

3.7

—

Drug-induced osteoporosis

293

2.14

6.13

7.0

3.7

—

Non-allergic asthma (mode)

752

6189

1.22

6.12

4.4

3.3

—

Malignant neoplasm of other connective and soft tissue

567

1.78

6.12

4.6

3.9

—

Coronary angioplasty

1060

9495

0.85

6.08

5.2

4.1

—

Injuries to the wrist and hand

4507

30266

1.09

6.08

3.9

3.7

—

Parkinson's disease, excluding more controls

469

3614

1.29

6.07

5.9

3.7

—

Rash and other nonspecific skin eruption

367

2818

1.33

6.07

5.5

4.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

156

1037

1.56

6.06

4.8

3.2

—

Juvenile rheumatoid arthirtis

101

606

1.75

6.05

4.7

3.0

—

Hyperprolactinaemia

148

974

1.58

6.04

4.0

3.4

—

Abnormality of white blood cells, not elsewhere classified

188

2.45

6.04

4.8

3.6

—

Malignant neoplasm of rectum

322

2429

1.36

6.04

4.6

4.2

—

Other symptoms and signs involving the urinary system

356

2726

1.33

5.99

7.2

3.6

—

Sequelae of injuries of upper limb

356

2728

1.33

5.97

4.6

3.7

—

Other peripheral vascular diseases

302

2262

1.37

5.97

4.6

3.9

—

Polyarteritis nodosa and related conditions

344

2.02

5.97

7.0

3.8

—

TMD muscular pain linked with fibromyalgia

235

2.28

5.97

5.1

3.2

—

Other benign neoplasms of uterus

201

1411

1.47

5.94

6.5

5.0

—

Carcinoma in situ of skin of scalp and neck

437

1.88

5.93

7.3

3.8

—

Polyhydramnios

186

1286

1.49

5.93

3.4

3.1

—

Presbyopia

214

1517

1.45

5.92

4.0

3.7

—

Other and unspecified abdominal hernia

156

1043

1.55

5.91

5.5

4.0

—

Nummular dermatitis

297

2224

1.37

5.89

5.3

3.8

—

Sleep disorders

843

7110

1.20

5.88

4.6

3.5

—

L01XX Other antineoplastic agents

201

1413

1.47

5.88

5.0

4.3

—

Golimumab

132

852

1.61

5.87

5.0

3.3

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Microorganisms panel - Urine sediment

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS